{"meta":{"query_hash":"46dfdd0e24f0","filters":{"venue":"Journal of Managed Care & Specialty Pharmacy"},"cohort_total":52,"direct_labels_cover":0,"predictions_cover":52,"exported":52,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/46dfdd0e24f0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Managed+Care+%26+Specialty+Pharmacy"},"results":[{"id":"W1174528165","doi":"10.18553/jmcp.2015.21.9.s1","title":"New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; American Society of Transplantation; U.S. Department of Veterans Affairs","keywords":"Medicine; Context (archaeology); Pharmacy; Hepatitis C; Promotion (chess); Panel discussion; Population; Health care; Medical education; Family medicine; Immunology; Political science; Business","score_opus":0.066420816437532,"score_gpt":0.4022039364016684,"score_spread":0.3357831199641364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1174528165","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007964107,0.10698433,0.005834102,0.8602558,0.008588208,0.0003118202,0.00010913537,0.00007262734,0.009879934],"genre_scores_gemma":[0.16412234,0.32318568,0.081655204,0.40131325,0.017557038,0.0009324838,0.00053519243,0.00021729241,0.010481518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94631326,0.036476195,0.0051824064,0.0018770756,0.008257118,0.0018939931],"domain_scores_gemma":[0.8619237,0.09438949,0.006971289,0.0019515406,0.024946805,0.009817142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.102835074,0.0009896816,0.0010745365,0.0033467952,0.0036857282,0.007698994,0.0022183585,0.00784827,0.0024418437],"category_scores_gemma":[0.12578711,0.0008372339,0.0014478527,0.0025800562,0.0036533407,0.008742872,0.008802356,0.014731874,0.00076744193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020468466,0.00048073084,0.0046086786,0.0063714255,0.00022349293,0.0019489451,0.025800683,0.0010681145,0.0012140559,0.0070081237,0.40704644,0.54402465],"study_design_scores_gemma":[0.00014959248,0.0003506318,0.0069770245,0.03588575,0.00032417767,0.002251949,0.03529463,0.0015593417,0.0008823504,0.027124522,0.8888931,0.00030696593],"about_ca_topic_score_codex":0.0025935066,"about_ca_topic_score_gemma":0.008019069,"teacher_disagreement_score":0.102835074,"about_ca_system_score_codex":0.0064842254,"about_ca_system_score_gemma":0.017657816,"threshold_uncertainty_score":0.54385036},"labels":[],"label_agreement":null},{"id":"W2202332854","doi":"10.18553/jmcp.2015.21.11.982","title":"Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Administration (probate law); Immunotherapy; MEDLINE; Food and drug administration; Clinical Practice; Dermatology; Intensive care medicine; Family medicine; Immunology; Pharmacology; Immune system","score_opus":0.04688621297761729,"score_gpt":0.37005682723714584,"score_spread":0.32317061425952853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202332854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97387254,0.005565825,0.00019540006,0.005142691,0.00006149169,0.00013545685,0.0040513305,0.000040206618,0.010934953],"genre_scores_gemma":[0.9927664,0.0037262975,0.00051093695,0.00091144966,0.000042203064,0.000030505409,0.0011033491,0.000010434022,0.0008983688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965738,0.00031156043,0.00022737689,0.00033777434,0.0018171876,0.0007322973],"domain_scores_gemma":[0.99330395,0.00044956992,0.0027849937,0.0000969235,0.001769372,0.0015950819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011063894,0.0002802537,0.0002733378,0.001405486,0.00204364,0.0014398071,0.0010952887,0.0005630527,0.0037232505],"category_scores_gemma":[0.005615713,0.0002853076,0.00047454587,0.0038737678,0.0007248254,0.00045855562,0.00087160146,0.0007974283,0.00029212522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016994061,0.00009983779,0.95005333,0.00019712724,0.00008557873,0.00033482493,0.0010366173,0.00022281252,0.00034154928,0.00032987798,0.00793277,0.0391958],"study_design_scores_gemma":[0.000022715683,0.00009133701,0.9919099,0.00016873935,0.000051424176,0.00045374775,0.0024231807,0.00048253452,0.00006791035,0.000040244224,0.0042684297,0.00001988532],"about_ca_topic_score_codex":0.9686349,"about_ca_topic_score_gemma":0.9785615,"teacher_disagreement_score":0.9686349,"about_ca_system_score_codex":0.03769022,"about_ca_system_score_gemma":0.048801083,"threshold_uncertainty_score":0.273463},"labels":[],"label_agreement":null},{"id":"W2281295224","doi":"10.18553/jmcp.2016.22.4.381","title":"Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"Providence Health Care; University of Washington; Washington State University","keywords":"Medicine; Emergency department; Medical prescription; Medical emergency; Health care; Emergency medicine; Family medicine; Medical record; Nursing","score_opus":0.03557528796684232,"score_gpt":0.3324076329152418,"score_spread":0.29683234494839944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281295224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718827,0.00033836786,0.00005967022,0.00068428856,0.000017572265,0.00004737178,0.00023754683,0.00001178326,0.0014151891],"genre_scores_gemma":[0.99866784,0.00027211843,0.0001774116,0.0002453277,0.000020902888,0.000047266938,0.00019169673,0.0000034883758,0.0003739891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805164,0.0010628676,0.00014650176,0.00017427538,0.0002161273,0.00034861872],"domain_scores_gemma":[0.9908084,0.003259678,0.0031443993,0.00037714335,0.00055752986,0.0018529024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022789238,0.0002554951,0.00025498017,0.00034242743,0.00065235223,0.0009122538,0.0005777411,0.0006627593,0.0044545336],"category_scores_gemma":[0.01704526,0.00020852688,0.0008162281,0.0005405523,0.00023543082,0.00081174914,0.0012889593,0.0011047081,0.0002544044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003219505,0.0034944415,0.92918324,0.00018132018,0.00030508055,0.00018584255,0.0007724827,0.00033464294,0.00022602685,0.00010602904,0.0020447148,0.059946645],"study_design_scores_gemma":[0.000116020834,0.0017488044,0.9949091,0.00010118455,0.00014015847,0.00012825984,0.0011171099,0.00054257794,0.00011579941,0.000070607486,0.0010011379,0.0000093090985],"about_ca_topic_score_codex":0.008233683,"about_ca_topic_score_gemma":0.0105658565,"teacher_disagreement_score":0.008233683,"about_ca_system_score_codex":0.00082297664,"about_ca_system_score_gemma":0.0012751312,"threshold_uncertainty_score":0.016371548},"labels":[],"label_agreement":null},{"id":"W2342848062","doi":"10.18553/jmcp.2016.22.5.539","title":"Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Reimbursement; Medicine; Deductible; Medical prescription; Quartile; Retrospective cohort study; Cohort; Family medicine; Emergency medicine; Health care; Internal medicine; Actuarial science; Nursing; Confidence interval","score_opus":0.03015981882170532,"score_gpt":0.33390441544237304,"score_spread":0.3037445966206677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342848062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987312,0.00012521505,0.000033628556,0.00007061553,0.0000029058729,0.000009080702,0.00071683194,0.000001417985,0.00030917756],"genre_scores_gemma":[0.9992162,0.00004885326,0.0000683232,0.000022448454,0.000004310255,0.0000071894237,0.0005564297,0.0000010743983,0.00007516742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820983,0.0005101822,0.00019798565,0.00022450295,0.00048072884,0.0003766956],"domain_scores_gemma":[0.99102235,0.0017190403,0.005090214,0.0003127645,0.0008098742,0.0010457566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016920842,0.00021955464,0.00036857312,0.0008312731,0.0006852395,0.00087806163,0.0005228427,0.00040084927,0.0019005819],"category_scores_gemma":[0.008084853,0.00017619105,0.0008668289,0.0015040502,0.00031077283,0.00036599714,0.0005551205,0.00067358074,0.00010569129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086537664,0.000021658549,0.9992118,0.0000040046907,0.000046355854,0.000010950017,0.000025761232,0.000045634642,0.000011953505,0.000009406918,0.000051893367,0.00047398361],"study_design_scores_gemma":[0.000004151092,0.00004083122,0.9995065,0.000006316646,0.000020248266,0.000028287599,0.00006618769,0.0002418698,0.000010115866,0.000006611561,0.00006674861,0.000002248085],"about_ca_topic_score_codex":0.32799336,"about_ca_topic_score_gemma":0.35049582,"teacher_disagreement_score":0.32799336,"about_ca_system_score_codex":0.0031626008,"about_ca_system_score_gemma":0.0027906427,"threshold_uncertainty_score":0.65216845},"labels":[],"label_agreement":null},{"id":"W2401364644","doi":"10.18553/jmcp.2016.22.6.676","title":"Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Université de Montréal; Sanofi","keywords":"Warfarin; Prospective cohort study; Medicine; MEDLINE; Cohort study; Internal medicine; Atrial fibrillation; Political science","score_opus":0.062329631686486316,"score_gpt":0.3387078272128758,"score_spread":0.2763781955263895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401364644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910396,0.000074691736,0.00003827756,0.000026058058,0.0000031243185,0.000014988007,0.00052795553,0.0000023204793,0.00020868596],"genre_scores_gemma":[0.9989975,0.000076339515,0.000088444154,0.00003246819,0.000005833018,0.000020065625,0.0005613498,0.000001634467,0.00021640022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995276,0.00008529669,0.000044822522,0.00010823383,0.00014201258,0.00009201976],"domain_scores_gemma":[0.99832445,0.00021838934,0.00081368914,0.00012663173,0.00022434637,0.0002924675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006463748,0.0002869824,0.0003641347,0.00080055377,0.00077301316,0.0008421154,0.00046092673,0.0004855738,0.0019573448],"category_scores_gemma":[0.0020811914,0.00033031582,0.00067677937,0.0010951202,0.0002987102,0.00042410986,0.000364858,0.0007012258,0.00026737447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005537398,0.000026580536,0.9995504,0.0000020777672,0.00002021537,0.00001528084,0.000028950608,0.000011413713,0.000039894003,0.0000033592407,0.00003630984,0.00021006],"study_design_scores_gemma":[0.00000601703,0.00006649288,0.9995121,0.000002934679,0.0000146495,0.000054182616,0.00008483685,0.0001836901,0.0000151814265,0.000003827248,0.000053481293,0.0000025439394],"about_ca_topic_score_codex":0.17459956,"about_ca_topic_score_gemma":0.18253042,"teacher_disagreement_score":0.17459956,"about_ca_system_score_codex":0.0013012096,"about_ca_system_score_gemma":0.0010504393,"threshold_uncertainty_score":0.34716654},"labels":[],"label_agreement":null},{"id":"W2417977696","doi":"10.18553/jmcp.2015.21.12.1116","title":"Proceedings of the AMCP Partnership Forum: Breaking the Link Between Pain Management and Opioid Use Disorder","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Substance Abuse Prevention; Center for Substance Abuse Treatment; Substance Abuse and Mental Health Services Administration; Depomed; Office of National Drug Control Policy; York University; Purdue Pharma; Zogenix; Medical Center, University of Pittsburgh; University of Pittsburgh; Purdue University; Kaiser Permanente; U.S. Food and Drug Administration; CVS Health; Blue Cross Blue Shield of Massachusetts","keywords":"Opioid use disorder; Opioid; Pain management; General partnership; Chronic pain; Medicine; Psychiatry; Psychology; Psychotherapist; Political science; Physical therapy; Internal medicine","score_opus":0.041338335328335966,"score_gpt":0.31370339447129736,"score_spread":0.2723650591429614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417977696","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002254497,0.0035979482,0.0006464394,0.9346361,0.050355177,0.00025969365,0.00014459422,0.000038520328,0.008066968],"genre_scores_gemma":[0.07418976,0.018196821,0.007721441,0.64178807,0.16118145,0.0016802293,0.0008718823,0.00027159724,0.094098695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98231053,0.005890918,0.00093307515,0.0011218609,0.006328041,0.0034155883],"domain_scores_gemma":[0.9521557,0.010932604,0.0022356387,0.001008073,0.008615189,0.02505275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03188022,0.0012685208,0.00094134646,0.0012801643,0.011967653,0.007281742,0.002863137,0.019990131,0.0136721255],"category_scores_gemma":[0.040928125,0.0008559574,0.0016294585,0.0010428658,0.0033993705,0.0055842767,0.013576505,0.028613055,0.002264545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061034832,0.00036256938,0.0015159837,0.00020906812,0.00002568571,0.0006247648,0.0009433532,0.000108310756,0.0003602529,0.0023307148,0.962482,0.030976152],"study_design_scores_gemma":[0.00009486607,0.00015167378,0.00573899,0.0005328347,0.000026688296,0.00037887882,0.0024110512,0.00028837574,0.00027054304,0.0027841819,0.98726904,0.000052764673],"about_ca_topic_score_codex":0.009306732,"about_ca_topic_score_gemma":0.029413104,"teacher_disagreement_score":0.03188022,"about_ca_system_score_codex":0.0052640527,"about_ca_system_score_gemma":0.039757416,"threshold_uncertainty_score":0.16860068},"labels":[],"label_agreement":null},{"id":"W2511824391","doi":"10.18553/jmcp.2016.22.9.1064","title":"Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"Amgen","keywords":"Ivabradine; Medicine; Heart failure; Medicare Advantage; Formulary; Emergency medicine; Internal medicine; Cardiology; Heart rate; Health care; Pharmacology; Blood pressure","score_opus":0.009468308968254735,"score_gpt":0.30812053404780193,"score_spread":0.2986522250795472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511824391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794979,0.0012164237,0.002445729,0.002396666,0.0000624469,0.00025221534,0.004227431,0.000042934484,0.009858295],"genre_scores_gemma":[0.9973194,0.00026689973,0.00085587875,0.00028607497,0.000009113693,0.00008321708,0.00079034816,0.000004111649,0.00038490453],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972939,0.0018380065,0.00010262875,0.00015118718,0.00021561253,0.00039870408],"domain_scores_gemma":[0.9973544,0.0013798625,0.0005671108,0.000091438436,0.00030574153,0.0003014562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032830657,0.0007506397,0.0005483885,0.00065136846,0.00038765382,0.0012537916,0.0006782516,0.0007540043,0.0035858254],"category_scores_gemma":[0.009477921,0.00043537276,0.0014667482,0.0008992091,0.0003955088,0.0011018923,0.0011158691,0.0009401346,0.00017380132],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032180327,0.00094019936,0.181559,0.00032808344,0.0014451871,0.0004575751,0.00014920387,0.7672189,0.000569692,0.0059019267,0.0057150302,0.032497235],"study_design_scores_gemma":[0.0024881011,0.0048644575,0.22431466,0.00064438186,0.002235153,0.00053007377,0.0014610188,0.7430423,0.0011973431,0.0076498776,0.011441626,0.00013100529],"about_ca_topic_score_codex":0.075849704,"about_ca_topic_score_gemma":0.051447805,"teacher_disagreement_score":0.075849704,"about_ca_system_score_codex":0.008411148,"about_ca_system_score_gemma":0.004812787,"threshold_uncertainty_score":0.15081644},"labels":[],"label_agreement":null},{"id":"W2524035794","doi":"10.18553/jmcp.2016.22.10.1204","title":"Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Dutasteride; Finasteride; Medicine; Benign prostatic hyperplasia (BPH); 5 Alpha-Reductase Inhibitor; Urology; Hyperplasia; Erectile dysfunction; Internal medicine; Prostate","score_opus":0.06852659501174793,"score_gpt":0.37090273950568703,"score_spread":0.3023761444939391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524035794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815136,0.0005385145,0.00006341701,0.000098511584,0.000008506199,0.000016593372,0.0008854687,0.0000022119264,0.00023540312],"genre_scores_gemma":[0.99880326,0.00016577604,0.00007271264,0.00005165479,0.0000138604555,0.000016347642,0.0008384241,8.0367977e-7,0.000037322043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825543,0.00066919124,0.0002671016,0.00024022655,0.0003565737,0.00021145925],"domain_scores_gemma":[0.99480915,0.0009549487,0.0033334913,0.00013873099,0.00033765312,0.0004260903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001797538,0.00022113726,0.00043722292,0.0011086172,0.00033323176,0.0006193869,0.00040896412,0.00034198829,0.0007612467],"category_scores_gemma":[0.005078919,0.00024647338,0.0012266361,0.0015143169,0.00028448078,0.00035532648,0.000696377,0.0006023929,0.00006265831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027417977,0.00006374794,0.9982291,0.000017050328,0.00019278761,0.000030348772,0.000019437595,0.00014027859,0.000024083094,0.000022691129,0.00010844397,0.0008779628],"study_design_scores_gemma":[0.0000390252,0.00022375105,0.9983529,0.000022318276,0.0001371259,0.00009341601,0.00011087355,0.000796974,0.000044813627,0.00003268517,0.00014095353,0.0000051781385],"about_ca_topic_score_codex":0.012774945,"about_ca_topic_score_gemma":0.014531475,"teacher_disagreement_score":0.012774945,"about_ca_system_score_codex":0.0009610031,"about_ca_system_score_gemma":0.00080561906,"threshold_uncertainty_score":0.025401175},"labels":[],"label_agreement":null},{"id":"W2559773245","doi":"10.18553/jmcp.2016.16233","title":"Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech; Astellas Pharma; Janssen Scientific Affairs; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; GlaxoSmithKline; Pfizer; Allergan; Bristol-Myers Squibb","keywords":"Abiraterone acetate; Enzalutamide; Medicine; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Oncology; Docetaxel; Cancer; Urology; Gynecology; Androgen deprivation therapy; Confidence interval","score_opus":0.030423283707478124,"score_gpt":0.34325781161561675,"score_spread":0.31283452790813865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559773245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566585,0.0015514495,0.000075244636,0.00007679503,0.000009792618,0.000029809353,0.0020337163,0.0000031468937,0.0005542224],"genre_scores_gemma":[0.9975127,0.00042933054,0.0001249774,0.000066399,0.00002064202,0.000047038964,0.0016545207,0.0000028383631,0.00014153222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874276,0.00028771616,0.00023110774,0.00028165657,0.00031327797,0.00014360211],"domain_scores_gemma":[0.9941606,0.00096167205,0.00405259,0.00011114865,0.000188778,0.0005251876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001145066,0.00013992931,0.00043360732,0.0010475083,0.0003486167,0.0007152955,0.00046050688,0.00032915804,0.0017374157],"category_scores_gemma":[0.005115986,0.000203168,0.0010266835,0.0020065324,0.00014450795,0.00048031483,0.0004739946,0.0006326986,0.00013910104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012824002,0.00006590537,0.99513876,0.000049508217,0.00017758815,0.00004883767,0.000060574795,0.00011650248,0.000078030396,0.000021054098,0.00016482559,0.002795945],"study_design_scores_gemma":[0.00008245012,0.0004460528,0.9976667,0.000039065566,0.00015868567,0.00026346222,0.00015288954,0.0003486242,0.0000619685,0.00003768838,0.0007337484,0.0000085201855],"about_ca_topic_score_codex":0.0053945594,"about_ca_topic_score_gemma":0.007839594,"teacher_disagreement_score":0.0053945594,"about_ca_system_score_codex":0.00089608255,"about_ca_system_score_gemma":0.00090102863,"threshold_uncertainty_score":0.010726273},"labels":[],"label_agreement":null},{"id":"W2580021056","doi":"10.18553/jmcp.2017.23.2.214","title":"Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Myeloid leukemia; Emergency medicine; Health care; Internal medicine; Incidence (geometry); Intensive care medicine","score_opus":0.015540074172635065,"score_gpt":0.29812006386282514,"score_spread":0.28257998969019005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580021056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967899,0.0003570625,0.00059770665,0.00077788695,0.000009530723,0.00003209079,0.00070562755,0.0000044312305,0.00072585104],"genre_scores_gemma":[0.9990965,0.00012179885,0.00028478872,0.00006462091,0.0000072014964,0.000023324148,0.00031165968,0.0000010036305,0.000089181194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985404,0.00067604025,0.00011550132,0.00021561126,0.00015317617,0.00029925068],"domain_scores_gemma":[0.99655735,0.001655056,0.0012530629,0.00008364534,0.00014260449,0.00030838017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019350261,0.000379467,0.0005201954,0.00062178465,0.00036124102,0.0012553002,0.00059424597,0.0008734226,0.0025083213],"category_scores_gemma":[0.0073982677,0.00037465792,0.0017616986,0.0011289552,0.00036150546,0.000757686,0.000851734,0.0011306949,0.00010092022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040794464,0.00043522622,0.9339555,0.00007311387,0.00049678923,0.00034174134,0.00010155116,0.05708659,0.00008962491,0.0011984432,0.00060101756,0.0052124914],"study_design_scores_gemma":[0.0001994857,0.0006425362,0.71916854,0.00019612777,0.00046286153,0.00062123354,0.000877887,0.27440292,0.00016903432,0.0022031215,0.0010082452,0.00004802084],"about_ca_topic_score_codex":0.037266046,"about_ca_topic_score_gemma":0.026898742,"teacher_disagreement_score":0.037266046,"about_ca_system_score_codex":0.0041316934,"about_ca_system_score_gemma":0.002330913,"threshold_uncertainty_score":0.07409829},"labels":[],"label_agreement":null},{"id":"W2580331578","doi":"10.18553/jmcp.2017.23.2.125","title":"Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Family medicine; Medicine; MEDLINE; Agency (philosophy); Health care; Political science","score_opus":0.05962344223072856,"score_gpt":0.362654184564635,"score_spread":0.3030307423339064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580331578","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27333084,0.26901504,0.015863724,0.32363328,0.0013149972,0.00026168683,0.00035052162,0.000027309809,0.11620255],"genre_scores_gemma":[0.91074926,0.07295844,0.0032929624,0.010979478,0.000883127,0.00023366082,0.00007154089,0.000014032556,0.0008175702],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9654087,0.0303716,0.001026971,0.00035112308,0.0020615023,0.0007799897],"domain_scores_gemma":[0.7504333,0.23812853,0.0046718377,0.0008760744,0.0049360325,0.0009541502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041545235,0.00033775216,0.00043511845,0.0024400463,0.0016887375,0.004013168,0.000618195,0.002138017,0.0027471543],"category_scores_gemma":[0.06995583,0.00018576272,0.0007750106,0.004662885,0.0050887857,0.005729771,0.0029675276,0.0032509225,0.00015239167],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047033496,0.0005447022,0.035355825,0.014979188,0.0003282609,0.0025263217,0.32319087,0.0016274436,0.0006437643,0.20915575,0.022253858,0.3889237],"study_design_scores_gemma":[0.00027343168,0.00083092146,0.06314723,0.039634228,0.00041639226,0.0041697267,0.36839044,0.0023818733,0.0016392177,0.17938554,0.33946714,0.00026384115],"about_ca_topic_score_codex":0.0022977074,"about_ca_topic_score_gemma":0.0028194862,"teacher_disagreement_score":0.041545235,"about_ca_system_score_codex":0.004109073,"about_ca_system_score_gemma":0.0041029872,"threshold_uncertainty_score":0.21971476},"labels":[],"label_agreement":null},{"id":"W2582881778","doi":"10.18553/jmcp.2017.23.2.247","title":"Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Family medicine; Prescription drug; Anticancer drug; Drug approval; Orphan drug; Medical prescription; Drug; Health care; Pharmacology; Political science","score_opus":0.05968202333567807,"score_gpt":0.31493782344998567,"score_spread":0.2552558001143076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582881778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520214,0.009244416,0.0006884453,0.0039028977,0.00015498346,0.00010198512,0.0118780155,0.00003681113,0.021970984],"genre_scores_gemma":[0.9885512,0.0019223994,0.00053516857,0.0012591397,0.000075709446,0.000056617944,0.006792242,0.000014872374,0.0007927036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452174,0.0021747563,0.0008243627,0.0006193325,0.0011931784,0.0006667186],"domain_scores_gemma":[0.9691887,0.011330324,0.012566872,0.00062224054,0.0054389522,0.0008528766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004119942,0.00018536161,0.00030525608,0.0034401482,0.00036062993,0.0018815177,0.0005541703,0.000617416,0.0035924385],"category_scores_gemma":[0.029638011,0.00022729722,0.0010248354,0.0049301893,0.0005624777,0.0008952121,0.0010451792,0.00070941314,0.00031827675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008044639,0.00010935456,0.9361893,0.00039630363,0.0013395239,0.00029131418,0.0006877395,0.006883091,0.00023667757,0.0028756808,0.018801376,0.031385247],"study_design_scores_gemma":[0.00011964273,0.00018262453,0.9767436,0.00035454467,0.0005764823,0.00032872008,0.0012630865,0.0029178197,0.00049031124,0.00048400144,0.016492572,0.000046526704],"about_ca_topic_score_codex":0.10370664,"about_ca_topic_score_gemma":0.106051035,"teacher_disagreement_score":0.10370664,"about_ca_system_score_codex":0.0036159102,"about_ca_system_score_gemma":0.0020421126,"threshold_uncertainty_score":0.20620602},"labels":[],"label_agreement":null},{"id":"W2589158462","doi":"10.18553/jmcp.2017.23.3.355","title":"Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Medical prescription; Medicine; Prescription drug; Quarter (Canadian coin); Family medicine; Medicare Part D; Health care; Emergency medicine; Nursing; Economic growth; Economics","score_opus":0.06662123829369185,"score_gpt":0.3341867324161187,"score_spread":0.2675654941224268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589158462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702317,0.0001542709,0.00013531686,0.00047657362,0.000008648744,0.000022951237,0.0014109809,0.000016717713,0.0007513916],"genre_scores_gemma":[0.9978682,0.00012578136,0.00018667286,0.00018998358,0.000017520453,0.000025303789,0.0013182339,0.0000029421417,0.0002653748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988079,0.00023257107,0.00014951128,0.00020347384,0.0003380647,0.00026845638],"domain_scores_gemma":[0.99485886,0.0007539091,0.003121691,0.00014850021,0.00071765896,0.00039946934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013460045,0.00013110728,0.00020365947,0.00084781693,0.0004398335,0.0008834629,0.0005226558,0.00048437747,0.0015327425],"category_scores_gemma":[0.0067786863,0.00022590024,0.000644899,0.0012665669,0.0003579978,0.0008214684,0.0012193797,0.0010502498,0.00010741193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117213356,0.00010037021,0.9939255,0.000026793366,0.00007408081,0.000054325148,0.00024460812,0.00021766666,0.00019566706,0.00011862252,0.0007531051,0.0041721454],"study_design_scores_gemma":[0.0000042358124,0.00003543198,0.99867487,0.000014730227,0.000023889348,0.000051863954,0.00023390082,0.00039055644,0.000121156045,0.000032787197,0.0004129463,0.000003596818],"about_ca_topic_score_codex":0.047491897,"about_ca_topic_score_gemma":0.0707022,"teacher_disagreement_score":0.047491897,"about_ca_system_score_codex":0.0025203426,"about_ca_system_score_gemma":0.002550523,"threshold_uncertainty_score":0.09443092},"labels":[],"label_agreement":null},{"id":"W2589462389","doi":"10.18553/jmcp.2017.23.3.337","title":"Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of North Carolina at Chapel Hill; Gillings School of Public Health; AcademyHealth; Robert Wood Johnson Foundation","keywords":"Medicaid; Medical prescription; Copayment; Medicine; Baseline (sea); Population; Quarter (Canadian coin); Prescription drug; Medication adherence; Family medicine; Demography; Health insurance; Environmental health; Internal medicine; Health care; Nursing","score_opus":0.041861920922275156,"score_gpt":0.3965196124528042,"score_spread":0.35465769153052906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589462389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970824,0.0004198009,0.00028681385,0.00047287115,0.000032544915,0.000092247225,0.0006630396,0.000012779702,0.0009374907],"genre_scores_gemma":[0.99885964,0.00006790084,0.00017296229,0.00013057074,0.000022536955,0.00008640666,0.00039601713,0.0000032302914,0.0002607218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98693305,0.0073126084,0.00091487577,0.0012155665,0.0021724578,0.0014514882],"domain_scores_gemma":[0.9681566,0.021148572,0.007119025,0.0014908505,0.000676297,0.0014086377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009636723,0.0003268652,0.0010063411,0.00062392,0.0005261803,0.0010470803,0.00090690446,0.001219144,0.0030897567],"category_scores_gemma":[0.032474633,0.0002691659,0.002837033,0.0007478801,0.0006042502,0.0008391404,0.0011127769,0.0021081415,0.00012714835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011788102,0.0019379167,0.95980847,0.000112852795,0.0045254356,0.00021168053,0.0005054088,0.0028602178,0.0007516882,0.000424812,0.00078981306,0.016283574],"study_design_scores_gemma":[0.00009565803,0.0014687356,0.99524236,0.000018253573,0.00048182634,0.000033812004,0.000115614166,0.0019581676,0.00019089824,0.00011838512,0.00026647857,0.000009939459],"about_ca_topic_score_codex":0.020771764,"about_ca_topic_score_gemma":0.0115852505,"teacher_disagreement_score":0.020771764,"about_ca_system_score_codex":0.00156959,"about_ca_system_score_gemma":0.0013917338,"threshold_uncertainty_score":0.050964534},"labels":[],"label_agreement":null},{"id":"W2609767893","doi":"10.18553/jmcp.2017.23.5.566","title":"Exploring Electronic Medical Record and Self-Administered Medication Risk Screening Tools in a Primary Care Clinic","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Grey Nuns Community Hospital; University of Alberta","funders":"","keywords":"Medicine; Pharmacist; Health literacy; Health care; MEDLINE; Medical record; Family medicine; Electronic medical record; Pharmacy; Internal medicine","score_opus":0.19407124811116977,"score_gpt":0.46429965834549614,"score_spread":0.27022841023432637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609767893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715793,0.00027109432,0.00047224312,0.00022911311,0.000009966676,0.00021132268,0.0005418326,0.000021805,0.0010847439],"genre_scores_gemma":[0.9974528,0.00009921493,0.001709095,0.00019522935,0.000021596003,0.00016230758,0.00025574266,0.0000028142774,0.00010122649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863247,0.008428998,0.0013669778,0.0012212107,0.0020940665,0.00056401745],"domain_scores_gemma":[0.9693095,0.017835785,0.0075859935,0.0011764149,0.0029601662,0.0011321221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012454403,0.0002360156,0.0004968572,0.0021021662,0.000520525,0.0014623342,0.00057776313,0.0007849363,0.0017247875],"category_scores_gemma":[0.03163292,0.0003852467,0.0005941851,0.0018059853,0.00037649518,0.0011123641,0.0010615734,0.0006972858,0.00036523485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014294688,0.00029693692,0.99216825,0.000054032105,0.000061384075,0.00007733698,0.00048273295,0.00004249547,0.00015523087,0.00001933233,0.00015667395,0.0063426127],"study_design_scores_gemma":[0.00007754088,0.0012353777,0.9959629,0.00006058936,0.000062562525,0.0003102487,0.0008527789,0.0008988593,0.00017091993,0.0000436589,0.00031238428,0.000012168153],"about_ca_topic_score_codex":0.005532244,"about_ca_topic_score_gemma":0.0071736784,"teacher_disagreement_score":0.012454403,"about_ca_system_score_codex":0.0008644237,"about_ca_system_score_gemma":0.001174321,"threshold_uncertainty_score":0.06586599},"labels":[],"label_agreement":null},{"id":"W2617020364","doi":"10.18553/jmcp.2017.23.6.633","title":"The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"PTC Therapeutics; Sarepta Therapeutics; GlaxoSmithKline; Eli Lilly and Company","keywords":"Medicine; Duchenne muscular dystrophy; Diagnosis code; Cohort; Pharmacy; Health care; Cohort study; Medical prescription; Emergency medicine; Pediatrics; Family medicine; Internal medicine; Population; Environmental health","score_opus":0.014379722324745903,"score_gpt":0.315511823919588,"score_spread":0.3011321015948421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617020364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981365,0.00037357523,0.00006742775,0.00010888085,0.0000028098057,0.000016516176,0.00092813437,0.0000028360214,0.00036332433],"genre_scores_gemma":[0.9988483,0.00018810849,0.00015172033,0.000038028054,0.000008897034,0.000011267743,0.00070577,7.262576e-7,0.000047170503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991596,0.00025449737,0.00017161298,0.000097890545,0.00024839386,0.00006804603],"domain_scores_gemma":[0.99666685,0.00055985886,0.0022043998,0.000057950503,0.00025125948,0.00025958486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093464233,0.00022214444,0.0002680258,0.001729863,0.00028131704,0.0006213591,0.00042353012,0.00031747305,0.0008054363],"category_scores_gemma":[0.004549462,0.00016779252,0.0004974076,0.0013986236,0.00021392755,0.00039344464,0.00074450235,0.0003692834,0.00006210934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030038203,0.00003424874,0.9980799,0.000012578362,0.00006434035,0.000037189388,0.000016926939,0.00019741277,0.000028664866,0.000021953983,0.00014852804,0.0013283283],"study_design_scores_gemma":[0.0000048502784,0.000045064397,0.99834263,0.0000143350235,0.000036024845,0.00020501309,0.00008917791,0.0010992629,0.000028010649,0.000023448387,0.00010976888,0.000002474057],"about_ca_topic_score_codex":0.01919621,"about_ca_topic_score_gemma":0.025011055,"teacher_disagreement_score":0.01919621,"about_ca_system_score_codex":0.0013746945,"about_ca_system_score_gemma":0.00061582925,"threshold_uncertainty_score":0.038168967},"labels":[],"label_agreement":null},{"id":"W2619351549","doi":"10.18553/jmcp.2017.23.6-a.s34","title":"Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"David Geffen School of Medicine, University of California, Los Angeles; California State University, East Bay; Eisai; Memorial Sloan-Kettering Cancer Center; University of California, Los Angeles; City of Hope; Tufts Medical Center","keywords":"Medicine; Concordance; Oncology; Clinical Oncology; Intraclass correlation; Prostate cancer; Breast cancer; Internal medicine; Inter-rater reliability; Cancer; Family medicine; Gynecology; Statistics; Psychometrics; Clinical psychology","score_opus":0.27371123389672003,"score_gpt":0.4738505961901953,"score_spread":0.2001393622934753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619351549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96333516,0.002767848,0.015666725,0.0017622883,0.00016054917,0.001288754,0.00047713172,0.0000879507,0.014453541],"genre_scores_gemma":[0.98543733,0.00044878776,0.013010513,0.00017230622,0.000026369036,0.00050934014,0.00026646492,0.0000139843105,0.00011494961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8188105,0.111367635,0.016296465,0.005561905,0.044630963,0.0033325807],"domain_scores_gemma":[0.554073,0.29063332,0.07227381,0.017302955,0.059912995,0.0058039716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17327341,0.000656031,0.0013394265,0.008518026,0.0018401545,0.0043664845,0.0017604991,0.0010709098,0.00057717453],"category_scores_gemma":[0.28489646,0.00055205595,0.0024971173,0.005262375,0.004377843,0.0028959808,0.0069153723,0.0019775417,0.00012881793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081075006,0.00039754328,0.8430617,0.001223386,0.0018018351,0.00013739751,0.015469349,0.0036639469,0.0007878251,0.0039189965,0.0026854447,0.12604178],"study_design_scores_gemma":[0.0002050806,0.001558267,0.92145586,0.0023253255,0.00055466953,0.00034178147,0.018049875,0.025619645,0.0025529694,0.014511784,0.012491908,0.0003328071],"about_ca_topic_score_codex":0.005820004,"about_ca_topic_score_gemma":0.0073388726,"teacher_disagreement_score":0.17327341,"about_ca_system_score_codex":0.0060256803,"about_ca_system_score_gemma":0.0095910495,"threshold_uncertainty_score":0.91636837},"labels":[],"label_agreement":null},{"id":"W2690274894","doi":"10.18553/jmcp.2017.23.6-b.s2","title":"The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis","year":2017,"lang":"en","type":"review","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"Genentech; H. Lundbeck A/S; Acorda Therapeutics; Allergan; ACADIA Pharmaceuticals; Eisai; Sunovion; Teva Pharmaceutical Industries","keywords":"Psychosis; Parkinson's disease; Disease; Disease management; Medicine; MEDLINE; Psychiatry; Pathology; Political science","score_opus":0.061933536909485734,"score_gpt":0.3984877224697301,"score_spread":0.33655418556024436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2690274894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01422426,0.494429,0.00196536,0.46233946,0.00366918,0.0000568821,0.0000819414,0.00007161937,0.023162303],"genre_scores_gemma":[0.25347748,0.5742052,0.011988338,0.12982933,0.026474489,0.00014826162,0.00014241453,0.000059726906,0.0036747374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966402,0.0017017572,0.00043543402,0.0002628292,0.0007039647,0.00025580765],"domain_scores_gemma":[0.9897546,0.0065902313,0.0007946532,0.00015273987,0.0017208819,0.0009869098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010638886,0.0003460632,0.0008203491,0.0007420555,0.00088842056,0.0029010894,0.00097148126,0.0025056754,0.0019086201],"category_scores_gemma":[0.011570042,0.00021727597,0.0007227679,0.000554901,0.0015674132,0.0029097148,0.0015170303,0.0075177224,0.00039129838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049722526,0.00019298989,0.002797694,0.0023966827,0.0001210301,0.002518979,0.0011411859,0.001165259,0.0025919473,0.012098222,0.07521712,0.8992617],"study_design_scores_gemma":[0.00059863296,0.0012882032,0.014851892,0.009920539,0.00025714454,0.006047936,0.0029542642,0.0021674784,0.0013973754,0.028471382,0.9318899,0.0001552749],"about_ca_topic_score_codex":0.0014099382,"about_ca_topic_score_gemma":0.005637601,"teacher_disagreement_score":0.010638886,"about_ca_system_score_codex":0.002648831,"about_ca_system_score_gemma":0.0029431724,"threshold_uncertainty_score":0.05626452},"labels":[],"label_agreement":null},{"id":"W2785395993","doi":"10.18553/jmcp.2018.24.2.173","title":"Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"","keywords":"Medicine; Kidney disease; Pharmacy; Internal medicine; Randomized controlled trial; Medication therapy management; Nephrology; Pharmaceutical care; Cluster (spacecraft); Physical therapy; Pharmacist; Emergency medicine; Family medicine","score_opus":0.05018344472814139,"score_gpt":0.37036973219362135,"score_spread":0.32018628746547995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785395993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276525,0.0023719047,0.00050195697,0.00029113112,0.00023775073,0.002962169,0.00033953725,0.00005401973,0.00047634638],"genre_scores_gemma":[0.99308264,0.0007523639,0.0013238182,0.00032408754,0.00022048556,0.0035184803,0.00031806593,0.000009977335,0.0004500516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99223024,0.0049900934,0.0006600206,0.0010718859,0.0004946163,0.0005531365],"domain_scores_gemma":[0.9924452,0.0031413117,0.0017304157,0.0009298495,0.0006038581,0.0011494089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007851174,0.0013672814,0.004717261,0.0006914615,0.0006956464,0.0010671131,0.0012751848,0.0018635144,0.0034163517],"category_scores_gemma":[0.010217552,0.00094478735,0.006072642,0.00081594154,0.0011413438,0.0010758692,0.00081609044,0.0022582598,0.0002741301],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97999007,0.0048521394,0.0035202538,0.0005793335,0.005584978,0.000015286276,0.000050790317,0.00021632448,0.00034964134,0.000031166044,0.00022462697,0.00458536],"study_design_scores_gemma":[0.9156944,0.06312219,0.015178378,0.00005418287,0.0045706904,0.00001663129,0.000039487615,0.00085313676,0.00020109313,0.000097219745,0.000151967,0.000020618578],"about_ca_topic_score_codex":0.0044926456,"about_ca_topic_score_gemma":0.0060367086,"teacher_disagreement_score":0.007851174,"about_ca_system_score_codex":0.0016187661,"about_ca_system_score_gemma":0.002450003,"threshold_uncertainty_score":0.04152143},"labels":[],"label_agreement":null},{"id":"W2800541776","doi":"10.18553/jmcp.2018.24.5.464","title":"Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Toronto General Hospital; St. Michael's Hospital","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; Department of Medicine, University of Toronto; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Research Institute","keywords":"Medicine; Reimbursement; Public health; Family medicine; Hepatitis B; Hepatitis B virus; Christian ministry; Health care; Environmental health; Virology; Nursing; Economic growth; Political science","score_opus":0.06051758302697124,"score_gpt":0.35822636008654873,"score_spread":0.2977087770595775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800541776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097073,0.0003834799,0.00007178111,0.0003269322,0.000008406613,0.00007983034,0.0063967714,0.0000061611936,0.0017558213],"genre_scores_gemma":[0.996316,0.0003369601,0.000111467954,0.00011775552,0.000009914661,0.00006615964,0.002223255,0.0000054995576,0.000813141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998779,0.0000993046,0.00010773718,0.00018878715,0.00038241857,0.00044273207],"domain_scores_gemma":[0.9957956,0.00015542131,0.0019321265,0.00014323462,0.0011240541,0.0008496635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007630199,0.00038022042,0.0005097645,0.0015800942,0.0024732878,0.0012213761,0.0012728804,0.0005972537,0.0026980091],"category_scores_gemma":[0.0023159436,0.0005787784,0.0010860928,0.005336403,0.0008178147,0.00079085596,0.0014072272,0.0005695688,0.0003647161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004690664,0.000029068691,0.99759835,0.000033935223,0.000040863677,0.000044102122,0.00070658146,0.000029034085,0.000043584452,0.000029939305,0.00055273325,0.00084477745],"study_design_scores_gemma":[0.000009405136,0.000023330096,0.9984072,0.00002394783,0.000017624276,0.000024943041,0.0008682425,0.00008485718,0.000008383295,0.000008438544,0.00051835,0.000005297018],"about_ca_topic_score_codex":0.9744228,"about_ca_topic_score_gemma":0.9853918,"teacher_disagreement_score":0.025577188,"about_ca_system_score_codex":0.025149608,"about_ca_system_score_gemma":0.023304738,"threshold_uncertainty_score":0.18247402},"labels":[],"label_agreement":null},{"id":"W2883086901","doi":"10.18553/jmcp.2018.18058","title":"Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Migraine; Medical prescription; Population; Observational study; Emergency department; Diagnosis code; Prescription drug; Pediatrics; Emergency medicine; Psychiatry; Internal medicine","score_opus":0.06578407431193879,"score_gpt":0.3887354786487766,"score_spread":0.32295140433683783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883086901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675639,0.0058233263,0.002073815,0.0049218736,0.00014852447,0.00016853012,0.01602226,0.000022101534,0.0032555494],"genre_scores_gemma":[0.993364,0.0009366736,0.0009547899,0.00044658952,0.00009947649,0.00011699931,0.0037245816,0.000012326086,0.00034461287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996442,0.0014768945,0.0005553669,0.00059136853,0.0004669247,0.00046741075],"domain_scores_gemma":[0.990506,0.0034145054,0.0043794787,0.00037576095,0.0007411725,0.0005830338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004077611,0.00045080174,0.0006511854,0.0017949988,0.00047505327,0.0014342366,0.000851476,0.0005366799,0.0036810231],"category_scores_gemma":[0.01899955,0.00030525288,0.002853549,0.0031248694,0.0003382721,0.001068121,0.0011619007,0.00176996,0.00017281181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003060635,0.00008605365,0.98554754,0.00013107406,0.00086867274,0.00008726238,0.00008436364,0.0014506045,0.00003711952,0.0011573608,0.0017410468,0.00850292],"study_design_scores_gemma":[0.00004228785,0.000102586615,0.98818564,0.00017255722,0.0006239961,0.0002494547,0.00026333876,0.0066921487,0.0000712808,0.0018577595,0.0017244832,0.000014522732],"about_ca_topic_score_codex":0.022906719,"about_ca_topic_score_gemma":0.0305347,"teacher_disagreement_score":0.022906719,"about_ca_system_score_codex":0.0021973052,"about_ca_system_score_gemma":0.0019377006,"threshold_uncertainty_score":0.04554677},"labels":[],"label_agreement":null},{"id":"W2885976838","doi":"10.18553/jmcp.2018.24.8.759","title":"Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Medicine; Medicaid; Schizophrenia (object-oriented programming); Antipsychotic; Discontinuation; Paliperidone; Population; Randomized controlled trial; Inclusion and exclusion criteria; Internal medicine; Psychiatry; Environmental health; Alternative medicine","score_opus":0.018293389058894036,"score_gpt":0.31818188202287473,"score_spread":0.2998884929639807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885976838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96927357,0.0017716845,0.010394215,0.00328845,0.00010152939,0.002260401,0.009196868,0.00008973662,0.003623539],"genre_scores_gemma":[0.9864898,0.0006058758,0.0078154905,0.000515252,0.000026847665,0.0015378009,0.0019991356,0.000011276787,0.0009985446],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9871421,0.010589376,0.00030779786,0.00085456047,0.00032917628,0.0007769998],"domain_scores_gemma":[0.9732347,0.021444773,0.0029414024,0.00052086567,0.0006121179,0.0012460497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020239083,0.0012041717,0.0018160794,0.0010180271,0.00039392206,0.001872428,0.001808046,0.0021523528,0.0059729707],"category_scores_gemma":[0.03180833,0.0009799168,0.005770945,0.0007704271,0.00074052997,0.001402503,0.0016900926,0.0023894077,0.0004735213],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039307974,0.003582397,0.16968386,0.0017781096,0.006650063,0.00017860062,0.00044975016,0.7083366,0.0006742579,0.009068398,0.0038536293,0.05643628],"study_design_scores_gemma":[0.007535464,0.015458052,0.050712552,0.0007219024,0.006946879,0.00010745621,0.0005928195,0.8997127,0.001132525,0.0131156575,0.0037956894,0.00016830626],"about_ca_topic_score_codex":0.030967766,"about_ca_topic_score_gemma":0.020233018,"teacher_disagreement_score":0.030967766,"about_ca_system_score_codex":0.006127597,"about_ca_system_score_gemma":0.0073013436,"threshold_uncertainty_score":0.107035816},"labels":[],"label_agreement":null},{"id":"W2914798425","doi":"10.18553/jmcp.2019.25.2.205","title":"Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; COPD; Exacerbation; Spirometry; Obstructive lung disease; Population; Cohort; Retrospective cohort study; Cohort study; Intensive care medicine; Emergency medicine; Rate ratio; Internal medicine; Environmental health; Asthma","score_opus":0.01654945398978596,"score_gpt":0.3188176105558088,"score_spread":0.30226815656602285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914798425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993364,0.0000911724,0.000016311567,0.000051070652,0.0000021163573,0.000003979338,0.00035805718,0.0000014369909,0.00013939422],"genre_scores_gemma":[0.9994843,0.000039233488,0.00001608069,0.000021628619,0.0000062393215,0.0000051650813,0.00039821427,5.623792e-7,0.000028541583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.00013956995,0.00007483283,0.00012517712,0.00012197982,0.00011815295],"domain_scores_gemma":[0.99846673,0.00022630708,0.00082521397,0.000063079424,0.00012066258,0.00029806828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061411806,0.00021166888,0.00032647967,0.0009104902,0.0003658991,0.00066359394,0.0003391354,0.0005197473,0.0013458707],"category_scores_gemma":[0.002561603,0.00021787739,0.00062640785,0.0012131019,0.00032271264,0.00053196686,0.0005907611,0.0005845769,0.00018549846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033864093,0.000017499398,0.9995084,0.0000024982473,0.000031066636,0.000029465717,0.000024348532,0.000046469435,0.000037379035,0.000008924284,0.000060355796,0.00019970356],"study_design_scores_gemma":[0.000003865394,0.000032425716,0.9994916,0.0000022812894,0.0000102593485,0.00008881542,0.000072481016,0.00025384538,0.000009341395,0.000010433031,0.000022747276,0.0000019163779],"about_ca_topic_score_codex":0.013952719,"about_ca_topic_score_gemma":0.01034648,"teacher_disagreement_score":0.013952719,"about_ca_system_score_codex":0.00056521426,"about_ca_system_score_gemma":0.00041270902,"threshold_uncertainty_score":0.027743042},"labels":[],"label_agreement":null},{"id":"W2975189232","doi":"10.18553/jmcp.2019.25.10.1096","title":"Genome Diagnostics: Novel Strategies for Measuring Value","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"Stakeholder; Personalized medicine; Construct (python library); Comparative effectiveness research; Genetic testing; Construct validity; Test (biology); Computer science; Knowledge management; Medicine; Data science; Management science; Psychometrics; Bioinformatics; Alternative medicine; Pathology; Clinical psychology","score_opus":0.2896631934780353,"score_gpt":0.42010591160071287,"score_spread":0.13044271812267755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975189232","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015170844,0.01897998,0.8521419,0.0294325,0.0010917806,0.0014781288,0.0019149974,0.0006549081,0.07913491],"genre_scores_gemma":[0.33659947,0.0078704925,0.6409525,0.0042883335,0.0008139917,0.004027863,0.00068841915,0.00022638026,0.0045324764],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9070184,0.070718326,0.0038824985,0.0061621508,0.011364716,0.00085399323],"domain_scores_gemma":[0.82782537,0.1372388,0.007853299,0.015756112,0.0101185,0.0012078795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.083991215,0.0029138627,0.0020555474,0.01496864,0.0018943686,0.01480062,0.0037670257,0.0035521195,0.010355355],"category_scores_gemma":[0.20398176,0.0010564462,0.0021573736,0.014014751,0.019562254,0.023727091,0.010488047,0.005171135,0.0017168116],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013417243,0.000085875756,0.0055358806,0.0011892138,0.00028894338,0.00008158546,0.003225823,0.0016247651,0.00044616323,0.81861067,0.0045993696,0.16417749],"study_design_scores_gemma":[0.000049648566,0.00016579441,0.0032323257,0.001451121,0.00019389414,0.00024112481,0.0019088162,0.008820879,0.0012091049,0.94004184,0.042579107,0.00010633554],"about_ca_topic_score_codex":0.0033547748,"about_ca_topic_score_gemma":0.0022028657,"teacher_disagreement_score":0.083991215,"about_ca_system_score_codex":0.008480102,"about_ca_system_score_gemma":0.005471145,"threshold_uncertainty_score":0.4441933},"labels":[],"label_agreement":null},{"id":"W2991424058","doi":"10.18553/jmcp.2019.19174","title":"Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Medicaid; Pharmacy; Regimen; Protease inhibitor (pharmacology); Reverse-transcriptase inhibitor; Health care; Internal medicine; Pediatrics; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Family medicine","score_opus":0.012712894579016629,"score_gpt":0.29402682291888543,"score_spread":0.2813139283398688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991424058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955823,0.001404859,0.00005894872,0.0014041538,0.00002553031,0.000032707958,0.00031014314,0.000005689839,0.0011757268],"genre_scores_gemma":[0.9989243,0.00042749275,0.0001396744,0.00017627711,0.000041001782,0.000021819142,0.00017117885,0.0000010364892,0.000097322176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995746,0.00016901077,0.000037918875,0.000033294702,0.00007841748,0.00010685024],"domain_scores_gemma":[0.9986933,0.0002996261,0.0005577614,0.000026082049,0.000062225066,0.00036099227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009348241,0.00016112704,0.00017610202,0.00032127235,0.00029762404,0.00046591245,0.0002380539,0.0003400792,0.0018647547],"category_scores_gemma":[0.0042305207,0.000085512685,0.00055860187,0.00031143424,0.00014351582,0.00046156163,0.00058938685,0.0005816197,0.00007359436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035127334,0.0024915838,0.9030063,0.00016674337,0.00036493115,0.00009228374,0.00015094267,0.0012265351,0.00034427416,0.00036002183,0.0022386129,0.08604509],"study_design_scores_gemma":[0.00035116173,0.0013891729,0.9939346,0.00014079647,0.00025265952,0.00010096019,0.00025670294,0.0019503989,0.00015155789,0.00025719302,0.001205531,0.000009261319],"about_ca_topic_score_codex":0.0051764264,"about_ca_topic_score_gemma":0.010692956,"teacher_disagreement_score":0.0051764264,"about_ca_system_score_codex":0.00060178887,"about_ca_system_score_gemma":0.001375405,"threshold_uncertainty_score":0.01029259},"labels":[],"label_agreement":null},{"id":"W3094921969","doi":"10.18553/jmcp.2020.26.11.1464","title":"ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine","year":2020,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Medicine; Migraine; Nothing; Acute migraine; Alternative medicine; MEDLINE; Traditional medicine; Family medicine; Psychiatry; Political science","score_opus":0.048225278617834814,"score_gpt":0.39853962469529136,"score_spread":0.35031434607745654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094921969","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008869549,0.017514434,0.000186336,0.8879965,0.018541109,0.00011123554,0.0012864831,0.000019708905,0.06547463],"genre_scores_gemma":[0.195816,0.02013501,0.0013809318,0.72630095,0.046196185,0.00016452043,0.0009390519,0.000043216307,0.00902421],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926837,0.003587901,0.001227055,0.00047254833,0.0014431578,0.0005857243],"domain_scores_gemma":[0.95555323,0.028753696,0.0029271042,0.0009453094,0.009216708,0.0026039572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009335838,0.00021028511,0.00074427185,0.00066754536,0.0011996089,0.0013957574,0.0014060517,0.008318673,0.009630764],"category_scores_gemma":[0.10725549,0.00017279944,0.0011705562,0.0006587028,0.0007660851,0.0015070596,0.00072519714,0.006090284,0.0009437699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008738468,0.00010308507,0.008992916,0.0010241033,0.00030630812,0.0011749926,0.000372604,0.00018085093,0.00014254842,0.005128886,0.92951626,0.052183602],"study_design_scores_gemma":[0.0016952702,0.0005213353,0.028494295,0.012611366,0.0010549829,0.0026649227,0.0011256661,0.0006707773,0.0005816487,0.007195652,0.9432367,0.0001473928],"about_ca_topic_score_codex":0.0198127,"about_ca_topic_score_gemma":0.059692357,"teacher_disagreement_score":0.0198127,"about_ca_system_score_codex":0.003409166,"about_ca_system_score_gemma":0.008127637,"threshold_uncertainty_score":0.04937321},"labels":[],"label_agreement":null},{"id":"W3136296759","doi":"10.18553/jmcp.2021.27.4.426","title":"Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Odds ratio; Pharmacy; Logistic regression; Internal medicine; Family medicine","score_opus":0.027603361707892175,"score_gpt":0.3042887938218259,"score_spread":0.2766854321139337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136296759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984559,0.00034022226,0.000041035746,0.0003410974,0.000017609846,0.000026977528,0.00024845032,0.0000045593747,0.0005241574],"genre_scores_gemma":[0.9994197,0.0000876352,0.000082709994,0.00007751212,0.000016801698,0.000012234468,0.00017284484,9.605201e-7,0.00012956843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953205,0.002356324,0.0002927589,0.00043696596,0.0009554779,0.0006380206],"domain_scores_gemma":[0.9884384,0.0038320192,0.0042164354,0.00068299385,0.00057515904,0.002254974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004459215,0.00028824978,0.00043302323,0.00045193572,0.00069851725,0.0012298339,0.0008439132,0.00093676685,0.0012388227],"category_scores_gemma":[0.0165805,0.00032269757,0.0018711345,0.0009551379,0.00035587873,0.00061519945,0.000995771,0.0013580407,0.00007707625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009790794,0.00028459443,0.9948715,0.000013631952,0.00026585365,0.000020755502,0.000049258717,0.00015554637,0.00002884162,0.000030606152,0.00014029117,0.0031600804],"study_design_scores_gemma":[0.00005250718,0.000410219,0.99874413,0.000011386401,0.000119690274,0.000018071734,0.000052595387,0.0004652941,0.00001415907,0.000011476187,0.00009755559,0.000002888509],"about_ca_topic_score_codex":0.13389981,"about_ca_topic_score_gemma":0.1290338,"teacher_disagreement_score":0.13389981,"about_ca_system_score_codex":0.0023099466,"about_ca_system_score_gemma":0.0034056504,"threshold_uncertainty_score":0.26624084},"labels":[],"label_agreement":null},{"id":"W3187389031","doi":"10.18553/jmcp.2021.21164","title":"Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Pembrolizumab; Medicine; Oncology; Clinical trial; Internal medicine; Cancer; Immunotherapy","score_opus":0.03911643639606383,"score_gpt":0.35514061684716103,"score_spread":0.3160241804510972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187389031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363841,0.016957356,0.018043315,0.0027344672,0.0002230042,0.002523319,0.008917553,0.00014449403,0.014072447],"genre_scores_gemma":[0.99289215,0.0014077167,0.002865756,0.00025529953,0.0000352499,0.00039186212,0.0014746387,0.000013603352,0.00066368585],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957545,0.003263155,0.00013804706,0.00023948512,0.00029720418,0.00030765194],"domain_scores_gemma":[0.9898372,0.008279589,0.00087432447,0.00019380696,0.00036809366,0.000447031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008443036,0.0014471001,0.0017770877,0.0019496258,0.00025494833,0.0016478185,0.001575251,0.0011110811,0.00559964],"category_scores_gemma":[0.018668367,0.0006939784,0.0053188405,0.0014723017,0.00066976366,0.0013758838,0.0010948125,0.0018501661,0.00029254748],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015128485,0.0007273864,0.010475539,0.0015211897,0.0049538133,0.00019385402,0.00006030018,0.9298949,0.0005824544,0.0058106896,0.0018367652,0.02881456],"study_design_scores_gemma":[0.005996907,0.014116534,0.02704639,0.0010064251,0.0086906515,0.00062275503,0.0002931473,0.9267877,0.0012168017,0.009146882,0.0049543604,0.00012153462],"about_ca_topic_score_codex":0.010103374,"about_ca_topic_score_gemma":0.00552646,"teacher_disagreement_score":0.010103374,"about_ca_system_score_codex":0.007399637,"about_ca_system_score_gemma":0.003021277,"threshold_uncertainty_score":0.053688347},"labels":[],"label_agreement":null},{"id":"W3215057584","doi":"10.18553/jmcp.2021.21290","title":"Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Indirect costs; Medicine; Psychiatry; Health care; Attention deficit hyperactivity disorder; Health economics; Unemployment; Population; Productivity; Economic cost; Gerontology; Depression (economics); Government (linguistics); Demography; Public health; Environmental health; Economic growth; Business; Economics; Nursing","score_opus":0.02244338430373089,"score_gpt":0.33400114181795304,"score_spread":0.31155775751422216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215057584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912623,0.063425094,0.0016138201,0.065926686,0.0009176242,0.00021259568,0.023563527,0.00005833472,0.053020023],"genre_scores_gemma":[0.95974755,0.029676532,0.0011813829,0.002859001,0.00048397,0.0000757497,0.0048784986,0.000010224425,0.0010871543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991055,0.00035069237,0.000107755965,0.000051758903,0.00025825188,0.00012596686],"domain_scores_gemma":[0.9984705,0.00021130803,0.00062479184,0.00002317813,0.00043921426,0.00023108086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081766513,0.00032576115,0.0002590446,0.0019581488,0.0004684138,0.0013519053,0.0002647245,0.0005134602,0.0025787079],"category_scores_gemma":[0.0032214979,0.00011600393,0.00066806184,0.002157883,0.00029253744,0.0007669898,0.0010079588,0.0008712723,0.00018168728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002455658,0.00024162405,0.7746382,0.000997941,0.0013778461,0.0014228038,0.00072503433,0.0035340847,0.00035304276,0.009338591,0.06333003,0.14379528],"study_design_scores_gemma":[0.000048625312,0.00026810676,0.9220559,0.0030028652,0.0009713837,0.0020555742,0.0049138004,0.0050108815,0.00031946285,0.004872372,0.056409135,0.00007195023],"about_ca_topic_score_codex":0.027971813,"about_ca_topic_score_gemma":0.045080032,"teacher_disagreement_score":0.027971813,"about_ca_system_score_codex":0.0025934586,"about_ca_system_score_gemma":0.0017898704,"threshold_uncertainty_score":0.055617988},"labels":[],"label_agreement":null},{"id":"W4210450301","doi":"10.18553/jmcp.2022.28.2.157","title":"Burden of hospitalization for heart failure in the United States: a systematic literature review","year":2022,"lang":"en","type":"review","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Broadcom (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Indirect costs; MEDLINE; Diabetes mellitus; Systematic review; Internal medicine; Demography; Emergency medicine; Endocrinology","score_opus":0.04177637764311661,"score_gpt":0.36971123086539215,"score_spread":0.32793485322227556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210450301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026752364,0.99549747,0.00008830137,0.00023418128,0.00006833286,0.00012792682,0.0011151248,0.0000075469156,0.00018583798],"genre_scores_gemma":[0.031414807,0.9667846,0.00045541016,0.0002910568,0.000059748523,0.00027339466,0.0006395807,0.0000047711032,0.00007670026],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957157,0.0014734039,0.0015756454,0.00042212885,0.00065655453,0.0001566407],"domain_scores_gemma":[0.984617,0.010715225,0.0029435947,0.00021375329,0.0012977788,0.00021261943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051835324,0.0010515738,0.0056954124,0.011325761,0.00050005264,0.0012738209,0.0009912476,0.0009260958,0.003278723],"category_scores_gemma":[0.023253169,0.0008027136,0.006516168,0.011387806,0.0005086709,0.001360862,0.0012965914,0.0008676023,0.00018752686],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033247288,0.000018666924,0.0080417525,0.9093887,0.03441922,0.00013450829,0.00021396542,0.00016036705,0.00011931808,0.00025131542,0.0037400417,0.04317974],"study_design_scores_gemma":[0.00043536548,0.00027062147,0.038777597,0.7301303,0.21028599,0.0006943,0.0006031015,0.00020873692,0.00017776198,0.00047884043,0.017865287,0.00007210027],"about_ca_topic_score_codex":0.012171672,"about_ca_topic_score_gemma":0.034293734,"teacher_disagreement_score":0.012171672,"about_ca_system_score_codex":0.0024581803,"about_ca_system_score_gemma":0.0068472205,"threshold_uncertainty_score":0.027413487},"labels":[],"label_agreement":null},{"id":"W4226088426","doi":"10.18553/jmcp.2022.28.2.146","title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"National Institute for Health and Care Research","keywords":"Checklist; Economic evaluation; Context (archaeology); Health care; Public health; Stakeholder; Public relations; Medicine; Guideline; Political science; Psychology; Nursing; Law","score_opus":0.29192687209551105,"score_gpt":0.5341751292409163,"score_spread":0.2422482571454052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226088426","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026101389,0.06900628,0.23027176,0.11374205,0.040827394,0.1286421,0.3208454,0.011253949,0.082800925],"genre_scores_gemma":[0.019064704,0.072167434,0.3079341,0.029700467,0.007695898,0.3183704,0.22131234,0.0047604316,0.01899415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.48531243,0.31377336,0.1119766,0.008167418,0.07529483,0.005475287],"domain_scores_gemma":[0.2670116,0.3763275,0.09263197,0.040356193,0.21943974,0.0042330036],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35525686,0.0049135988,0.01158999,0.021256408,0.002628722,0.01905913,0.010345016,0.012894646,0.050401516],"category_scores_gemma":[0.72282916,0.004589986,0.0146547,0.03951825,0.005036842,0.010683548,0.008238486,0.022889776,0.029076176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012964626,0.00015623536,0.0011729292,0.04572259,0.0014568481,0.00013970165,0.0006835286,0.002375066,0.00020627986,0.023286175,0.8003899,0.123114355],"study_design_scores_gemma":[0.0020586853,0.00024829182,0.0034484847,0.0876812,0.0016839181,0.00027241788,0.0004582882,0.0036220998,0.0010300562,0.03775299,0.8612835,0.00046006986],"about_ca_topic_score_codex":0.010802657,"about_ca_topic_score_gemma":0.0056097256,"teacher_disagreement_score":0.64474314,"about_ca_system_score_codex":0.013931755,"about_ca_system_score_gemma":0.05262755,"threshold_uncertainty_score":0.7950831},"labels":[],"label_agreement":null},{"id":"W4245507582","doi":"10.18553/jmcp.2020.26.1.55","title":"AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Defense Health Agency; University of Massachusetts Medical School; U.S. Food and Drug Administration; National Pharmaceutical Council; Mallinckrodt Pharmaceuticals; American Pharmacists Association; Ohio State University; Case Western Reserve University; National Psoriasis Foundation","keywords":"Prior authorization; Authorization; General partnership; Selection (genetic algorithm); Legislature; Medicine; Political science; Computer science; Pharmacology; Computer security; Artificial intelligence; Law","score_opus":0.20727745877756928,"score_gpt":0.43419884096173844,"score_spread":0.22692138218416916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245507582","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0080444245,0.0033812874,0.008730524,0.94480413,0.012832832,0.00089389266,0.0005471035,0.00028687902,0.020478893],"genre_scores_gemma":[0.22785352,0.019247424,0.10670978,0.51261973,0.039073452,0.004121431,0.0031980318,0.0007972793,0.08637937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93683785,0.03644812,0.002333967,0.003436066,0.015196939,0.0057470333],"domain_scores_gemma":[0.80498236,0.079746805,0.01161383,0.007117377,0.037490834,0.059048712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10735005,0.0010619865,0.00064409676,0.0017811753,0.008964866,0.009898064,0.0040348168,0.015043096,0.014131624],"category_scores_gemma":[0.1137348,0.0006943885,0.0014360148,0.0017595448,0.0034029554,0.013076649,0.01589813,0.014759709,0.00286398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011520536,0.0013178815,0.0037779084,0.00046157005,0.000029745108,0.0005322088,0.00409631,0.0005087701,0.0011124936,0.012451623,0.8189629,0.15663345],"study_design_scores_gemma":[0.000110687004,0.00040956598,0.0023860594,0.00081990374,0.00001589211,0.00026402596,0.003933624,0.0009090207,0.000861839,0.009865059,0.9803578,0.000066371016],"about_ca_topic_score_codex":0.0031938173,"about_ca_topic_score_gemma":0.008922349,"teacher_disagreement_score":0.10735005,"about_ca_system_score_codex":0.006331669,"about_ca_system_score_gemma":0.0694703,"threshold_uncertainty_score":0.56772816},"labels":[],"label_agreement":null},{"id":"W4293102417","doi":"10.18553/jmcp.2022.28.9.958","title":"Treatment persistence and adherence in people with type 2 diabetes switching to iGlarLixi vs free-dose combinations of basal insulin and glucagon-like peptide 1 receptor agonist","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Basal insulin; Persistence (discontinuity); Agonist; Type 2 diabetes; Basal (medicine); Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Insulin; Endocrinology; Internal medicine; Receptor; Diabetes mellitus","score_opus":0.01925624183233251,"score_gpt":0.2697511568846674,"score_spread":0.2504949150523349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293102417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985844,0.00047536558,0.00014009584,0.000072942414,0.000013626858,0.000023596802,0.00044761933,0.0000027577446,0.00023975038],"genre_scores_gemma":[0.99894446,0.00012878067,0.00010633219,0.00007381448,0.00002011982,0.000046538185,0.0005662114,0.0000014713694,0.00011228798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781454,0.00084878306,0.0003521174,0.00044284182,0.00031418123,0.00022762243],"domain_scores_gemma":[0.99655557,0.001039022,0.0018299164,0.0002242703,0.00013581578,0.00021539847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036069707,0.00023158263,0.00062681217,0.0008158615,0.00041152354,0.0007794905,0.00049137796,0.0005619239,0.0017623922],"category_scores_gemma":[0.007039022,0.00026158657,0.0022852884,0.0013453568,0.00025254692,0.0005214722,0.0005957405,0.0009068175,0.000121118675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003015285,0.0001858894,0.9906088,0.00007055047,0.0014232186,0.000032800475,0.00007187084,0.00023555792,0.000044034477,0.00005454927,0.00026575776,0.003991614],"study_design_scores_gemma":[0.00049040996,0.0013365565,0.99242425,0.00008650852,0.0012762034,0.00015649125,0.00031617834,0.0030997656,0.00009913561,0.00022486396,0.0004764685,0.000013147551],"about_ca_topic_score_codex":0.0051554786,"about_ca_topic_score_gemma":0.0038413303,"teacher_disagreement_score":0.0051554786,"about_ca_system_score_codex":0.0005862771,"about_ca_system_score_gemma":0.0004541659,"threshold_uncertainty_score":0.019075751},"labels":[],"label_agreement":null},{"id":"W4307427140","doi":"10.18553/jmcp.2022.28.11.1213","title":"COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Coronavirus disease 2019 (COVID-19); Pharmacy; Medicine; 2019-20 coronavirus outbreak; MEDLINE; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Psoriasis; Family medicine; Virology; Dermatology; Disease; Internal medicine; Infectious disease (medical specialty); Political science","score_opus":0.09957264582041192,"score_gpt":0.3783236926464389,"score_spread":0.27875104682602697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307427140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131,0.0010844277,0.00039625177,0.0007073983,0.00003155476,0.0000871278,0.013816105,0.000014787754,0.0025523123],"genre_scores_gemma":[0.9909168,0.00038671063,0.0006087538,0.0001044411,0.000048898346,0.00006641061,0.0074563073,0.000012301891,0.00039932798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98934305,0.004585177,0.0019046935,0.0008662736,0.0026876344,0.0006132153],"domain_scores_gemma":[0.9661836,0.011539173,0.01687779,0.0023056436,0.0016582737,0.0014354839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007082147,0.00023688536,0.00061482313,0.0033970692,0.00043731087,0.0016836678,0.0008318345,0.0006060232,0.003600319],"category_scores_gemma":[0.017895693,0.0003135471,0.0014516754,0.0073950044,0.00031145354,0.0008866214,0.00115616,0.0014727735,0.00042338096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028841707,0.00006223856,0.99609214,0.000040601386,0.00030476577,0.000045348963,0.000034631827,0.00007420959,0.00005758531,0.00008094132,0.00050041795,0.0024187258],"study_design_scores_gemma":[0.000036807338,0.00012693368,0.9962077,0.00006106985,0.0001693078,0.0002340667,0.00023526467,0.0017143902,0.000088380126,0.00008239568,0.0010301631,0.000013435956],"about_ca_topic_score_codex":0.009809146,"about_ca_topic_score_gemma":0.013894381,"teacher_disagreement_score":0.009809146,"about_ca_system_score_codex":0.00084326405,"about_ca_system_score_gemma":0.0011897361,"threshold_uncertainty_score":0.037454426},"labels":[],"label_agreement":null},{"id":"W4310049761","doi":"10.18553/jmcp.2022.28.12.1410","title":"Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hyperkalemia; Prior authorization; Intensive care medicine; Kidney disease; Formulary; Medical emergency; Family medicine; Nursing; Internal medicine","score_opus":0.027327840231749456,"score_gpt":0.3605037094673068,"score_spread":0.33317586923555736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310049761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98095936,0.0011134981,0.0010401511,0.005223586,0.00008052145,0.00028149333,0.00059747207,0.000075452124,0.010628402],"genre_scores_gemma":[0.99619603,0.0006064855,0.0013042918,0.0011659929,0.000058825182,0.000052650656,0.00021561707,0.000009527563,0.00039059873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99436086,0.00234554,0.0011681394,0.0003652173,0.001196327,0.0005639142],"domain_scores_gemma":[0.95906126,0.017872557,0.018010061,0.00074171234,0.002274451,0.002039927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004029535,0.000110798974,0.00014387137,0.00093713915,0.0011347294,0.0010319002,0.0004626929,0.0004844497,0.004936245],"category_scores_gemma":[0.0396344,0.00018918885,0.00025245978,0.00079768104,0.00049663516,0.0007881423,0.0012180888,0.0008311226,0.00032606442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034188206,0.00030635967,0.9194448,0.00043552124,0.000048123125,0.0025784927,0.00437967,0.00031224318,0.0011371457,0.0012428488,0.008495955,0.06127699],"study_design_scores_gemma":[0.000064402164,0.0010334164,0.9388763,0.0016301884,0.00006462217,0.009369437,0.020401469,0.0020851928,0.0013825106,0.0008798985,0.024137251,0.000075300646],"about_ca_topic_score_codex":0.005575432,"about_ca_topic_score_gemma":0.0153928865,"teacher_disagreement_score":0.005575432,"about_ca_system_score_codex":0.0019146785,"about_ca_system_score_gemma":0.005371332,"threshold_uncertainty_score":0.021310508},"labels":[],"label_agreement":null},{"id":"W4310050139","doi":"10.18553/jmcp.2022.28.12.1392","title":"A dynamic analysis of medication adherence","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medication adherence; Medicine; Medical prescription; Observational study; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.03377093411223851,"score_gpt":0.3632091920977731,"score_spread":0.32943825798553455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310050139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88423,0.001535893,0.07873367,0.009048078,0.00016769016,0.00017548905,0.0077485815,0.00025130768,0.01810926],"genre_scores_gemma":[0.9782683,0.0004806492,0.005125028,0.00020418319,0.0001158074,0.00011103725,0.0019243486,0.000028605136,0.013742033],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9987552,0.0005571328,0.000042576292,0.00027395904,0.00013573264,0.00023539507],"domain_scores_gemma":[0.9962112,0.0025727963,0.0006090938,0.00021210808,0.00017671949,0.00021817553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021409264,0.00037606797,0.00091844774,0.0013737902,0.00054242014,0.0013917264,0.0008390521,0.000982989,0.011421747],"category_scores_gemma":[0.009338065,0.00038616094,0.0013697468,0.0014333015,0.0004155633,0.0011095722,0.0010679634,0.0015341332,0.00088531343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001147476,0.000884047,0.25290632,0.00020969399,0.001894002,0.0008212655,0.00086282927,0.44072458,0.0023421573,0.16188234,0.014805114,0.12152021],"study_design_scores_gemma":[0.00009586581,0.00037599332,0.111250155,0.00005988257,0.00026561416,0.00023091334,0.00034066624,0.84021735,0.00024358394,0.037879534,0.008974825,0.00006564112],"about_ca_topic_score_codex":0.030884294,"about_ca_topic_score_gemma":0.013821812,"teacher_disagreement_score":0.030884294,"about_ca_system_score_codex":0.0015536014,"about_ca_system_score_gemma":0.0014411048,"threshold_uncertainty_score":0.061409056},"labels":[],"label_agreement":null},{"id":"W4367550171","doi":"10.18553/jmcp.2023.29.5.499","title":"Place of care and costs associated with acute episodes and remission in schizophrenia","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Clozapine; Schizophrenia (object-oriented programming); Emergency department; Acute care; Inpatient care; Diagnosis of schizophrenia; Psychiatry; Antipsychotic; Ambulatory care; Managed care; Emergency medicine; Health care; Pediatrics; Psychosis","score_opus":0.017100901820344166,"score_gpt":0.3222262041200625,"score_spread":0.3051253022997183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367550171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718493,0.0076489146,0.0001814291,0.006087924,0.00021471456,0.000046801262,0.0049429373,0.000013918315,0.009014145],"genre_scores_gemma":[0.996819,0.0016648627,0.00012821323,0.00010899346,0.000109761706,0.00001965535,0.00081931823,0.0000058549813,0.00032425192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981504,0.0007098884,0.00033085622,0.000083335995,0.00039420626,0.0003312082],"domain_scores_gemma":[0.98574924,0.002311286,0.008734852,0.00026393877,0.0007074235,0.002233197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010245012,0.00014124707,0.00032886662,0.0019056014,0.00071975484,0.0013623241,0.00056018354,0.00047992697,0.006846017],"category_scores_gemma":[0.019457744,0.00019269084,0.0006133783,0.0032549147,0.00030383395,0.00094787235,0.0013015729,0.0011745241,0.00029207315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005689081,0.00011594956,0.9700959,0.00021284797,0.00019607968,0.000369787,0.0003999371,0.00030992448,0.000033957145,0.0011001019,0.0042705755,0.022326078],"study_design_scores_gemma":[0.000020796957,0.000060495735,0.99613345,0.00023979685,0.00005063712,0.00033914347,0.0012097561,0.0003897569,0.0000135187265,0.00055926264,0.00096931646,0.000014011198],"about_ca_topic_score_codex":0.029421728,"about_ca_topic_score_gemma":0.02582191,"teacher_disagreement_score":0.029421728,"about_ca_system_score_codex":0.0023892485,"about_ca_system_score_gemma":0.0018052455,"threshold_uncertainty_score":0.058500946},"labels":[],"label_agreement":null},{"id":"W4378549192","doi":"10.18553/jmcp.2023.22417","title":"Identifying potentially undiagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease: Development of a predictive algorithm using claims data","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Insmed","keywords":"Medicine; COPD; Comorbidity; Chronic bronchitis; Internal medicine; Retrospective cohort study; Bronchiectasis; Obstructive lung disease; Cohort; Logistic regression; Intensive care medicine; Lung","score_opus":0.030648692227508868,"score_gpt":0.32172441483576236,"score_spread":0.2910757226082535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378549192","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335719,0.0027665538,0.04939354,0.0033360366,0.00029022584,0.0013254457,0.0025468965,0.00071891624,0.00605056],"genre_scores_gemma":[0.94536793,0.0008860203,0.05035441,0.00028511693,0.00015212732,0.0003300292,0.0020810692,0.000026009542,0.00051726325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969903,0.0013999331,0.00045256357,0.0003659511,0.0006211189,0.00017006732],"domain_scores_gemma":[0.9894889,0.006947328,0.0013118918,0.0003422224,0.0014339269,0.00047570548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058683227,0.0008952799,0.0012858246,0.005674655,0.0006054317,0.002964786,0.0017201803,0.001182201,0.001539073],"category_scores_gemma":[0.023465019,0.0005341338,0.0011191373,0.0023240668,0.00036575962,0.0014040793,0.0013850915,0.0018809196,0.0005375804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001075662,0.00095431414,0.89243454,0.00014774555,0.0004016558,0.00022298023,0.00012123883,0.008701875,0.00044964015,0.0007628269,0.0039483537,0.09077913],"study_design_scores_gemma":[0.0005446193,0.0010009839,0.34507477,0.00041375947,0.000829172,0.0011870184,0.0006143295,0.64085096,0.0017691371,0.0045375074,0.0030740122,0.00010369311],"about_ca_topic_score_codex":0.0038742903,"about_ca_topic_score_gemma":0.0049930015,"teacher_disagreement_score":0.0058683227,"about_ca_system_score_codex":0.0007681315,"about_ca_system_score_gemma":0.0014052605,"threshold_uncertainty_score":0.031035006},"labels":[],"label_agreement":null},{"id":"W4379390237","doi":"10.18553/jmcp.2023.29.6.671","title":"Pharmacists’ chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; COPD; Pulmonary disease; Disease management; Emergency department; Pharmacist; Pulmonary function testing; Emergency medicine; Health care; Disease; Internal medicine; Physical therapy; Family medicine; Pharmacy; Nursing","score_opus":0.028798097865915858,"score_gpt":0.369254444798583,"score_spread":0.34045634693266713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379390237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98801255,0.0034507175,0.000048131216,0.0028046726,0.00004611849,0.000042677693,0.0008990067,0.000008081995,0.0046878722],"genre_scores_gemma":[0.9971572,0.0013127066,0.00009597461,0.00019386885,0.000060423212,0.000013211815,0.00034066034,0.0000031790441,0.0008227982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982601,0.00087134365,0.00011435559,0.00010704353,0.0003204311,0.0003266984],"domain_scores_gemma":[0.9911868,0.0032809381,0.0021547393,0.00022919751,0.000544759,0.002603649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728616,0.00017390444,0.0004285758,0.0006434476,0.00063071214,0.00085736054,0.00053039956,0.00069190346,0.0050894353],"category_scores_gemma":[0.012640402,0.0001988063,0.0012731816,0.001164449,0.00029701117,0.0005181933,0.0011983276,0.0011370633,0.0002694031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018432894,0.0012523183,0.9598078,0.00014403583,0.00057208433,0.00010649056,0.00017582458,0.00016535015,0.0000837643,0.0001194042,0.0017524345,0.033977155],"study_design_scores_gemma":[0.0000655501,0.00028428758,0.99879175,0.000039754766,0.000116258314,0.000036641308,0.000118485186,0.00014298476,0.000013548561,0.000027897711,0.0003588408,0.000003979738],"about_ca_topic_score_codex":0.10314335,"about_ca_topic_score_gemma":0.14401092,"teacher_disagreement_score":0.10314335,"about_ca_system_score_codex":0.0014934315,"about_ca_system_score_gemma":0.003958608,"threshold_uncertainty_score":0.20508593},"labels":[],"label_agreement":null},{"id":"W4380319259","doi":"10.18553/jmcp.2023.23013","title":"Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Indirect costs; Gerontology; Total cost; Medicaid; Demography; Health care","score_opus":0.4449090573847032,"score_gpt":0.4941077475740367,"score_spread":0.04919869018933348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380319259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135345,0.0015213621,0.00021748096,0.001131406,0.000025346919,0.000027092683,0.0029723062,0.00000829602,0.0027433333],"genre_scores_gemma":[0.9965783,0.00077726506,0.00039148453,0.00012379642,0.000022726377,0.000028462884,0.0017363135,0.0000024074022,0.00033931254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990773,0.00051495794,0.00012328134,0.00005825609,0.0001619344,0.00006421004],"domain_scores_gemma":[0.99742186,0.0008195699,0.0010296826,0.00007289683,0.00023098924,0.00042497745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016762216,0.00017706733,0.00021745027,0.0016395608,0.00029323078,0.00075040944,0.00036227255,0.000295073,0.001627862],"category_scores_gemma":[0.006322226,0.00013374585,0.0005145852,0.0015832479,0.00018526672,0.000584976,0.0007503751,0.0008361955,0.00014786595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019309379,0.0002242631,0.98137146,0.00004574738,0.00019639343,0.000069302274,0.00008205421,0.000846147,0.00002048624,0.0004151108,0.0029972424,0.013538759],"study_design_scores_gemma":[0.000018344797,0.00011082474,0.99568695,0.000080056125,0.000063632135,0.0001190242,0.0004214367,0.002221345,0.000027953061,0.00038346657,0.00085978454,0.000007141315],"about_ca_topic_score_codex":0.030116467,"about_ca_topic_score_gemma":0.040653005,"teacher_disagreement_score":0.030116467,"about_ca_system_score_codex":0.0013790886,"about_ca_system_score_gemma":0.00082360505,"threshold_uncertainty_score":0.059882343},"labels":[],"label_agreement":null},{"id":"W4383186570","doi":"10.18553/jmcp.2023.29.7.758","title":"Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Olaparib; Cohort; Taxane; Breast cancer; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.09824664513683765,"score_gpt":0.43613664796998347,"score_spread":0.33789000283314585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383186570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995948,0.0009487132,0.00028862493,0.0003794851,0.000088219764,0.0010339477,0.0006586986,0.000046187164,0.0006081553],"genre_scores_gemma":[0.9926428,0.00076624326,0.0012341373,0.0010019888,0.00016105206,0.0018757607,0.0015229812,0.000013943177,0.00078110566],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991861,0.00046996865,0.000024397643,0.00014960783,0.00007409982,0.0000958061],"domain_scores_gemma":[0.9992223,0.00010385194,0.00014679685,0.00007310102,0.000061024395,0.0003929848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018756266,0.0013893003,0.001673526,0.00039454363,0.00041874798,0.0010127573,0.000993167,0.0010664256,0.0027057363],"category_scores_gemma":[0.0011072266,0.00056427094,0.0019063387,0.00043025205,0.0009972084,0.00074227125,0.00049771706,0.0027613726,0.00047391962],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77737,0.11062834,0.015249705,0.0006562628,0.002211585,0.0001941458,0.0002866811,0.0014591012,0.019264333,0.00017457725,0.0026965006,0.06980879],"study_design_scores_gemma":[0.7248711,0.24918643,0.022584666,0.000018767638,0.00037966945,0.00018282142,0.000048062335,0.00090935756,0.0006803249,0.00010967616,0.000998389,0.000030729254],"about_ca_topic_score_codex":0.0006657303,"about_ca_topic_score_gemma":0.0012672523,"teacher_disagreement_score":0.0027057363,"about_ca_system_score_codex":0.0007329726,"about_ca_system_score_gemma":0.0012152357,"threshold_uncertainty_score":0.009919345},"labels":[],"label_agreement":null},{"id":"W4385415391","doi":"10.18553/jmcp.2023.29.8.896","title":"Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Major depressive disorder; Adjunctive treatment; Psychiatry; Resource use; Bipolar disorder; Schizophrenia (object-oriented programming); MEDLINE; Health care; Mood","score_opus":0.04567015405411958,"score_gpt":0.3411468752849681,"score_spread":0.29547672123084856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385415391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962567,0.00045387633,0.000034850436,0.00012057211,0.0000040923246,0.000019572753,0.0027480465,0.0000028724064,0.00035947314],"genre_scores_gemma":[0.9971244,0.00027274227,0.000091237926,0.000056904923,0.000009369423,0.000029122428,0.0023257663,0.0000021432359,0.00008834064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986791,0.00028184333,0.00030360123,0.00025143826,0.0002907426,0.00019326081],"domain_scores_gemma":[0.99605906,0.00059128244,0.0027297025,0.00008203411,0.0002596558,0.00027827529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008823839,0.00022342872,0.00036277281,0.0014791539,0.0003311542,0.00084074517,0.0006268674,0.0004073185,0.0014348058],"category_scores_gemma":[0.0050022653,0.00025989462,0.00069659966,0.002676602,0.00019746195,0.0005345563,0.0006184298,0.0006403329,0.00014996131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023714118,0.00005171611,0.9974154,0.000019932158,0.00010765547,0.00004650898,0.00003426242,0.00012725324,0.000033505934,0.000026119596,0.00034646364,0.001553943],"study_design_scores_gemma":[0.00001781448,0.000051857904,0.99866796,0.000020194055,0.00003985092,0.00010998365,0.00016847931,0.0007242491,0.000029360775,0.000026024341,0.00013972154,0.000004501973],"about_ca_topic_score_codex":0.032552183,"about_ca_topic_score_gemma":0.040253405,"teacher_disagreement_score":0.032552183,"about_ca_system_score_codex":0.0018516135,"about_ca_system_score_gemma":0.0010343136,"threshold_uncertainty_score":0.0647254},"labels":[],"label_agreement":null},{"id":"W4386084628","doi":"10.18553/jmcp.2023.29.9.1045","title":"Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Ejection fraction; Heart failure with preserved ejection fraction; Cost effectiveness; Hazard ratio; Heart failure; Intensive care medicine; Internal medicine; Emergency medicine; Diabetes mellitus; Type 2 diabetes; Risk analysis (engineering); Confidence interval","score_opus":0.026722205193785323,"score_gpt":0.3308528337624001,"score_spread":0.3041306285686148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9233312,0.031526323,0.023741966,0.002786387,0.00045474022,0.0031043317,0.005483025,0.00017431524,0.009397704],"genre_scores_gemma":[0.9925662,0.0021552353,0.0034197676,0.00022864806,0.0000597171,0.0004593739,0.0008257764,0.000011933115,0.00027336765],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954585,0.0033731444,0.00023727278,0.000285229,0.00032990193,0.00031607552],"domain_scores_gemma":[0.9850448,0.013036424,0.00088567147,0.00023377867,0.00033282454,0.00046657852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009273927,0.0014822904,0.0035726302,0.0023502682,0.00026276015,0.0017496794,0.0012954429,0.0014934934,0.0048805163],"category_scores_gemma":[0.023300339,0.0006902941,0.008173463,0.001281117,0.00051412475,0.0016078799,0.0010184301,0.0018120058,0.00017115226],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1156873,0.0024099073,0.020129511,0.0044903103,0.026900295,0.0004850423,0.00010909668,0.7441048,0.0011087047,0.0086803585,0.0023281963,0.07356657],"study_design_scores_gemma":[0.028974108,0.024392543,0.021546405,0.0016501173,0.040278226,0.0007559847,0.0002574499,0.8664826,0.0013875465,0.01127984,0.0027767594,0.00021846363],"about_ca_topic_score_codex":0.005970596,"about_ca_topic_score_gemma":0.0031394095,"teacher_disagreement_score":0.009273927,"about_ca_system_score_codex":0.005160764,"about_ca_system_score_gemma":0.0024132861,"threshold_uncertainty_score":0.0490458},"labels":[],"label_agreement":null},{"id":"W4396723201","doi":"10.18553/jmcp.2024.23324","title":"Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Lupus nephritis; Medicine; MEDLINE; Intensive care medicine; Internal medicine; Disease; Political science","score_opus":0.1251450861698361,"score_gpt":0.4600347434019011,"score_spread":0.334889657232065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396723201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6627226,0.22112323,0.007993955,0.02729833,0.0016158615,0.0064373515,0.038162187,0.00025099103,0.034395516],"genre_scores_gemma":[0.9652242,0.01995083,0.004402057,0.0026852402,0.00019829054,0.0016071297,0.005265948,0.000029113,0.00063720794],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9898851,0.008025916,0.000647845,0.00030167119,0.00076479284,0.00037464866],"domain_scores_gemma":[0.976716,0.015962493,0.0038992085,0.00035716762,0.0020406276,0.0010244726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013975127,0.001072716,0.0017066345,0.0019835634,0.00031270733,0.0021280928,0.00093509984,0.0016154797,0.00523131],"category_scores_gemma":[0.050036687,0.00059915485,0.004925861,0.0025616884,0.00046908608,0.0013070437,0.0009816978,0.0018211225,0.00026778365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0799012,0.0054038297,0.12230117,0.027757773,0.049065948,0.0007539862,0.00027228254,0.30659667,0.0009585753,0.017286662,0.054664522,0.3350374],"study_design_scores_gemma":[0.052564245,0.04931563,0.2435609,0.04067083,0.10154777,0.0018699005,0.0016161704,0.39318612,0.0032034633,0.026688261,0.085170634,0.0006061417],"about_ca_topic_score_codex":0.01964506,"about_ca_topic_score_gemma":0.013837095,"teacher_disagreement_score":0.01964506,"about_ca_system_score_codex":0.008333059,"about_ca_system_score_gemma":0.006730913,"threshold_uncertainty_score":0.07390845},"labels":[],"label_agreement":null},{"id":"W4401392934","doi":"10.18553/jmcp.2024.24025","title":"Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Diabetes mellitus; Perspective (graphical); Medicine; Continuous glucose monitoring; Microsimulation; Basal insulin; Insulin; Type 2 diabetes; Blood Glucose Self-Monitoring; Type 2 Diabetes Mellitus; Basal (medicine); Type 1 diabetes; Intensive care medicine; Internal medicine; Computer science; Endocrinology; Engineering","score_opus":0.01961952572042414,"score_gpt":0.33435348394074993,"score_spread":0.3147339582203258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401392934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9168611,0.003429732,0.055343673,0.004273366,0.0001826619,0.0010275444,0.003190942,0.00014662354,0.015544389],"genre_scores_gemma":[0.9866448,0.0008563861,0.007776056,0.00030931705,0.000050081126,0.0006170141,0.0005879232,0.00001714868,0.003141177],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99845684,0.0010291265,0.00003908927,0.00014321203,0.000101748745,0.00023003112],"domain_scores_gemma":[0.99420434,0.0047214064,0.0004859191,0.00007474519,0.0002389108,0.00027469502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043463297,0.0016169293,0.0020465974,0.0019543867,0.0005316723,0.0021776864,0.001532253,0.002358229,0.0058882097],"category_scores_gemma":[0.009874848,0.00082272926,0.0034098772,0.0012977583,0.00075429317,0.0015211955,0.0012610705,0.0017959593,0.0002835493],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004666947,0.00017280134,0.003233076,0.00007934891,0.00027471865,0.00010599119,0.000027182032,0.98837835,0.00011284953,0.0039520855,0.00042068068,0.0027763352],"study_design_scores_gemma":[0.00019828555,0.00050707127,0.0014316876,0.000044304034,0.00031328705,0.000052491156,0.000062101666,0.99522334,0.00006690909,0.0017473933,0.00033221752,0.000020950527],"about_ca_topic_score_codex":0.032849155,"about_ca_topic_score_gemma":0.013583192,"teacher_disagreement_score":0.032849155,"about_ca_system_score_codex":0.0063866465,"about_ca_system_score_gemma":0.003728667,"threshold_uncertainty_score":0.0653159},"labels":[],"label_agreement":null},{"id":"W4402830730","doi":"10.18553/jmcp.2024.30.10.1136","title":"A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Allergan; Bausch Health; Takeda Pharmaceuticals U.S.A.; Coloplast; University of Miami; Alnylam Pharmaceuticals","keywords":"Persistence (discontinuity); Medicine; Medical prescription; Medication adherence; Constipation; Real world evidence; Chronic disease; Family medicine; Internal medicine; Nursing","score_opus":0.031667870013039896,"score_gpt":0.3199147153283446,"score_spread":0.2882468453153047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402830730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983145,0.00019514754,0.00006040876,0.00008765516,0.000006614788,0.000021063453,0.0010300155,0.0000022525846,0.00028226356],"genre_scores_gemma":[0.9987269,0.00009366104,0.00009891597,0.000084899824,0.000011812058,0.000027416467,0.0008946337,0.000001164305,0.00006064069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982822,0.0006806805,0.0002463607,0.0002818907,0.00031474725,0.00019420238],"domain_scores_gemma":[0.9947271,0.0007572547,0.003180175,0.0004136115,0.000441064,0.00048075046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020399215,0.0002449158,0.00033408997,0.00096450443,0.0007217275,0.0008929312,0.00040831883,0.00066768157,0.0011929434],"category_scores_gemma":[0.00538338,0.00032172873,0.00054803584,0.0016399116,0.0004099649,0.00068231137,0.0007302482,0.0009149876,0.00020976306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004782723,0.00006929728,0.99932575,0.000006611683,0.000049281283,0.000017453487,0.0000615433,0.000009361086,0.000018398323,0.000008286939,0.00009316888,0.00029293064],"study_design_scores_gemma":[0.000015818065,0.00015810365,0.9989311,0.000012164793,0.00003396983,0.0001483607,0.00031039887,0.00015320454,0.000015810476,0.000012439314,0.00020427592,0.0000043536947],"about_ca_topic_score_codex":0.012962147,"about_ca_topic_score_gemma":0.01546486,"teacher_disagreement_score":0.012962147,"about_ca_system_score_codex":0.00061240984,"about_ca_system_score_gemma":0.0007713182,"threshold_uncertainty_score":0.025773346},"labels":[],"label_agreement":null},{"id":"W4403862361","doi":"10.18553/jmcp.2024.30.11.1318","title":"Unlocking the potential of digital therapeutics: The need for consistent and granular inclusion in drug compendia for managed care","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Drug; Medicine; Inclusion (mineral); MEDLINE; Medical emergency; Drug approval; Intensive care medicine; Pharmacology; Psychology; Chemistry","score_opus":0.03273581422332697,"score_gpt":0.37809850193007616,"score_spread":0.34536268770674916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403862361","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023567954,0.013122659,0.046814524,0.7940623,0.0041112746,0.0013034932,0.0009157066,0.0024368905,0.11366513],"genre_scores_gemma":[0.23343176,0.019924903,0.41416407,0.29376766,0.009594836,0.0019108752,0.0032241547,0.0009827093,0.022999054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9210709,0.025918214,0.010007099,0.0045575267,0.035353266,0.003093044],"domain_scores_gemma":[0.65640604,0.18195054,0.03272332,0.05717401,0.046574995,0.025171092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10312082,0.0005512714,0.0011758455,0.008330814,0.0068162745,0.027539184,0.005472819,0.0066668056,0.008961678],"category_scores_gemma":[0.22433916,0.0012710607,0.0017236228,0.0064422977,0.010766224,0.03239357,0.013157893,0.014435963,0.002666862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008725292,0.000518619,0.0127201,0.0008855125,0.00007269412,0.00030128693,0.0037328878,0.00093597156,0.001449939,0.17575723,0.21716207,0.5863765],"study_design_scores_gemma":[0.00010918184,0.00033183082,0.023946406,0.0046103355,0.0000728213,0.00079258543,0.0026088494,0.002787773,0.001231721,0.11173983,0.85152,0.00024865425],"about_ca_topic_score_codex":0.015746854,"about_ca_topic_score_gemma":0.025394179,"teacher_disagreement_score":0.10312082,"about_ca_system_score_codex":0.012960025,"about_ca_system_score_gemma":0.066731595,"threshold_uncertainty_score":0.5453615},"labels":[],"label_agreement":null},{"id":"W4404850065","doi":"10.18553/jmcp.2024.30.12.1349","title":"Fear of missing out: Drug availability in the United States vs Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Agency for Healthcare Research and Quality","keywords":"Drug; MEDLINE; Medicine; Environmental health; Pharmacology; Political science; Law","score_opus":0.04763722699797736,"score_gpt":0.3059557295201401,"score_spread":0.25831850252216276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404850065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524614,0.002867227,0.00036219906,0.00938798,0.0000535237,0.000105184416,0.009089728,0.00001543233,0.025657209],"genre_scores_gemma":[0.996567,0.0007542854,0.00012861798,0.0008035121,0.000018504737,0.00001621168,0.0012350217,0.000004867973,0.00047194524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679595,0.00042723108,0.0002516916,0.00032135315,0.0014527566,0.0007509832],"domain_scores_gemma":[0.9760779,0.0044514597,0.0109803565,0.00039359272,0.004489266,0.0036073592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002892989,0.000122048725,0.00035925081,0.0020524852,0.0018339361,0.0018840636,0.0010069688,0.0005473671,0.004168261],"category_scores_gemma":[0.0153683135,0.00016903415,0.00058571826,0.0065228916,0.001520893,0.0010523023,0.0014307227,0.0016636844,0.00013418552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083008264,0.000026441365,0.9908524,0.000045451907,0.00006917718,0.00008938552,0.0007018603,0.00017556801,0.000018549012,0.0007202731,0.0029769868,0.004241039],"study_design_scores_gemma":[0.00000914858,0.000026282118,0.99157625,0.00019815234,0.00006559307,0.0001464162,0.0036123497,0.00068507413,0.000056164314,0.00027314582,0.0033307734,0.000020762593],"about_ca_topic_score_codex":0.94577956,"about_ca_topic_score_gemma":0.9584642,"teacher_disagreement_score":0.054220438,"about_ca_system_score_codex":0.017005408,"about_ca_system_score_gemma":0.023429248,"threshold_uncertainty_score":0.12338346},"labels":[],"label_agreement":null},{"id":"W4406526102","doi":"10.18553/jmcp.2025.24253","title":"Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus – An economic evaluation","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Diabetes Canada","funders":"","keywords":"Glucagon-like peptide 1 receptor; Medicine; Continuous glucose monitoring; Type 2 Diabetes Mellitus; Agonist; Diabetes mellitus; Glucagon-like peptide-1; Internal medicine; Type 2 diabetes; Endocrinology; Receptor; Type 1 diabetes","score_opus":0.05746476984958627,"score_gpt":0.4000279298708894,"score_spread":0.34256316002130316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406526102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8326947,0.097865045,0.02358922,0.0070259683,0.0011989726,0.0032466485,0.004511817,0.00017144445,0.029696204],"genre_scores_gemma":[0.98594147,0.0077125793,0.0041716434,0.0003428795,0.00010714321,0.0004222831,0.0005787157,0.000012194451,0.0007110855],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99304056,0.0057821157,0.00017695803,0.00018554984,0.00053711014,0.00027771285],"domain_scores_gemma":[0.9899997,0.008234935,0.0006363732,0.00015198904,0.00047279944,0.0005042213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010272097,0.001829171,0.0025844995,0.0019164647,0.0003081776,0.0023511103,0.001180083,0.0015614488,0.0049147853],"category_scores_gemma":[0.022801584,0.0006116542,0.005553384,0.0015509629,0.0005087231,0.001548725,0.000924856,0.0020916336,0.00016775861],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061893135,0.0024825083,0.01609646,0.007505231,0.014809427,0.00076531013,0.000083843726,0.73867893,0.0007412924,0.009881184,0.0044172807,0.1426454],"study_design_scores_gemma":[0.020252485,0.025679233,0.022055782,0.004630621,0.029785303,0.0008703298,0.00025876035,0.87630695,0.001234,0.0074553196,0.011280787,0.0001904064],"about_ca_topic_score_codex":0.008706136,"about_ca_topic_score_gemma":0.0059445,"teacher_disagreement_score":0.010272097,"about_ca_system_score_codex":0.005261301,"about_ca_system_score_gemma":0.0039362484,"threshold_uncertainty_score":0.054324687},"labels":[],"label_agreement":null},{"id":"W4410906154","doi":"10.18553/jmcp.2025.31.6.578","title":"Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Hereditary angioedema; Medicine; MEDLINE; Angioedema; Family medicine; Dermatology; Political science","score_opus":0.009725072763414408,"score_gpt":0.29833216811034863,"score_spread":0.28860709534693424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410906154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990274,0.0003171222,0.00004428018,0.000093426985,0.0000055634864,0.000004670953,0.00020421261,0.0000044110216,0.00029878024],"genre_scores_gemma":[0.9995989,0.000088478584,0.000038814596,0.000030097552,0.000004790328,0.0000035974176,0.00015576262,5.354626e-7,0.000078986435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996866,0.000114652656,0.000032631473,0.00004929085,0.000058923422,0.00005796875],"domain_scores_gemma":[0.99903035,0.00018320525,0.0005789135,0.000030382142,0.000061574,0.00011560748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041946932,0.000090520996,0.00016888932,0.00020613041,0.00016820067,0.00020642937,0.00014679602,0.00016209109,0.0012232454],"category_scores_gemma":[0.0021159763,0.00008786857,0.0002851765,0.00023534398,0.0000707586,0.00017045406,0.00018454721,0.00039096765,0.000055992467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032156162,0.0001581052,0.99154437,0.000024389334,0.000088979315,0.000043404612,0.0000654309,0.00009842558,0.00014872369,0.000026367961,0.0004344395,0.0070459293],"study_design_scores_gemma":[0.000021944472,0.00014188827,0.9991652,0.000010039211,0.000036091988,0.000076676246,0.00006829366,0.00028858107,0.000052207888,0.000013566779,0.00012410109,0.0000014579124],"about_ca_topic_score_codex":0.007694591,"about_ca_topic_score_gemma":0.011379102,"teacher_disagreement_score":0.007694591,"about_ca_system_score_codex":0.00034535443,"about_ca_system_score_gemma":0.00029542347,"threshold_uncertainty_score":0.015299618},"labels":[],"label_agreement":null},{"id":"W4412489576","doi":"10.18553/jmcp.2025.25051","title":"Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Obesity; Indirect costs; Weight loss; Observational study; Systematic review; Cohort study; Medical costs; MEDLINE; Cost–benefit analysis; Demography; Gerontology; Internal medicine; Health care","score_opus":0.014195685886307685,"score_gpt":0.31333427592544505,"score_spread":0.29913859003913734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412489576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002185725,0.9953176,0.00012479267,0.0002965224,0.00006888263,0.00024751117,0.001374328,0.000008774054,0.00037592952],"genre_scores_gemma":[0.022883,0.97490907,0.00064824405,0.0003498499,0.00005972197,0.00047697386,0.00058057986,0.0000058083783,0.00008675055],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.993135,0.002108819,0.0029253855,0.0004096451,0.0012204872,0.00020059654],"domain_scores_gemma":[0.9694224,0.021762518,0.006298121,0.00028426026,0.001992519,0.00024015592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006312028,0.0016883863,0.0065754,0.018837376,0.0006053065,0.0028546017,0.0015877918,0.0014707553,0.003580102],"category_scores_gemma":[0.039959975,0.0011252456,0.008177944,0.01804205,0.0006486177,0.0019335304,0.0015910176,0.0010984464,0.00021334252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017848033,0.000016518676,0.0027016825,0.9504484,0.015272363,0.00015106963,0.00014080218,0.00024655147,0.00006183068,0.0002994738,0.0017896106,0.02869322],"study_design_scores_gemma":[0.00020250666,0.0001421422,0.010215045,0.8928179,0.08278637,0.0006177978,0.00031397014,0.00020958889,0.00011327919,0.00043710496,0.012106038,0.00003828494],"about_ca_topic_score_codex":0.014232462,"about_ca_topic_score_gemma":0.030659478,"teacher_disagreement_score":0.018837376,"about_ca_system_score_codex":0.0049111582,"about_ca_system_score_gemma":0.010773447,"threshold_uncertainty_score":0.035633087},"labels":[],"label_agreement":null},{"id":"W4413427728","doi":"10.18553/jmcp.2025.24302","title":"Changes in urine albumin-to-creatinine ratio and health care resource utilization and costs in patients with type 2 diabetes and chronic kidney disease","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Creatinine; Kidney disease; Diabetes mellitus; Urine; Type 2 diabetes; Albumin; Disease; Intensive care medicine; Albuminuria; Internal medicine; Health care; Urology; Endocrinology","score_opus":0.012184667022061679,"score_gpt":0.304678814540722,"score_spread":0.2924941475186603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413427728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956601,0.001229031,0.000096985474,0.00024414324,0.00001784725,0.000023272052,0.0020782875,0.000005661692,0.0006445656],"genre_scores_gemma":[0.99787915,0.00036071346,0.00016619338,0.00008525012,0.000032550302,0.00003218004,0.0013394438,0.000001963654,0.000102500926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863464,0.00048301005,0.00024889398,0.0001705414,0.00031181343,0.00015109863],"domain_scores_gemma":[0.99599385,0.00075465365,0.0025318516,0.00011027232,0.00024921875,0.00036019765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015167559,0.00033056847,0.00050745177,0.001666322,0.00035194555,0.00089286105,0.0005776574,0.00051410444,0.0013555159],"category_scores_gemma":[0.005773712,0.00025738482,0.0008019185,0.0031473956,0.00026133828,0.0006628762,0.000671843,0.0009603881,0.0001645202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070501934,0.00004722027,0.9989567,0.000015656096,0.00008955467,0.000020880678,0.000011798911,0.0000945087,0.000007895416,0.00001039513,0.00012341714,0.00055153965],"study_design_scores_gemma":[0.000011077395,0.000047605434,0.99900836,0.000012179142,0.000045875884,0.000076215954,0.000052060437,0.0006130175,0.000014191342,0.00002561482,0.00009019582,0.0000037777502],"about_ca_topic_score_codex":0.01481955,"about_ca_topic_score_gemma":0.013323675,"teacher_disagreement_score":0.01481955,"about_ca_system_score_codex":0.0010448826,"about_ca_system_score_gemma":0.00071711786,"threshold_uncertainty_score":0.029466629},"labels":[],"label_agreement":null}]}